###begin article-title 0
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism
###end article-title 0
###begin p 1
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL2</italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL9</italic>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 538 539 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 584 591 584 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 666 673 666 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 830 837 830 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 870 871 870 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 908 909 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 924 925 924 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1316 1323 1316 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 786 791 <span type="species:ncbi:9606">human</span>
Analysis of variants in three genes encoding oxysterol-binding protein (OSBP) homologues (OSBPL2, OSBPL9, OSBPL10) in Finnish families with familial low high-density lipoprotein (HDL) levels (N = 426) or familial combined hyperlipidemia (N = 684) revealed suggestive linkage of OSBPL10 single-nucleotide polymorphisms (SNPs) with extreme end high triglyceride (TG; >90th percentile) trait. Prompted by this initial finding, we carried out association analysis in a metabolic syndrome subcohort (Genmets) of Health2000 examination survey (N = 2,138), revealing association of multiple OSBPL10 SNPs with high serum TG levels (>95th percentile). To investigate whether OSBPL10 could be the gene underlying the observed linkage and association, we carried out functional experiments in the human hepatoma cell line Huh7. Silencing of OSBPL10 increased the incorporation of [3H]acetate into cholesterol and both [3H]acetate and [3H]oleate into triglycerides and enhanced the accumulation of secreted apolipoprotein B100 in growth medium, suggesting that the encoded protein ORP10 suppresses hepatic lipogenesis and very-low-density lipoprotein production. ORP10 was shown to associate dynamically with microtubules, consistent with its involvement in intracellular transport or organelle positioning. The data introduces OSBPL10 as a gene whose variation may contribute to high triglyceride levels in dyslipidemic Finnish subjects and provides evidence for ORP10 as a regulator of cellular lipid metabolism.
###end p 1
###begin title 2
Electronic supplementary material
###end title 2
###begin p 3
The online version of this article (doi:10.1007/s00109-009-0490-z) contains supplementary material, which is available to authorized users.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL</italic>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 282 288 <span type="species:ncbi:9606">humans</span>
Families of proteins with homology to the carboxy-terminal ligand binding domain of oxysterol binding protein (OSBP) are suggested to function in various cellular processes such as lipid metabolism, intracellular lipid transport, membrane trafficking, and cell signaling [1, 2]. In humans, the gene family consists of 12 members, which are denoted OSBP-like genes (OSBPL), while the encoded proteins are called either OSBP-like (OSBPL) or OSBP-related proteins (ORP) [3, 4].
###end p 6
###begin p 7
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 842 843 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 1051 1052 1051 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1220 1222 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 344 349 <span type="species:ncbi:10090">mouse</span>
###xml 665 670 <span type="species:ncbi:9606">human</span>
###xml 680 685 <span type="species:ncbi:10090">mouse</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
OSBP is the most extensively studied member of the mammalian ORP protein family. OSBP acts as a sterol sensor that integrates the cellular sterol status with sphingomyelin metabolism [5] and controls the dephosphorylation and hence the activity of extracellular signal-regulated kinases, ERK [6]. We recently showed that OSBP overexpression in mouse liver impacts serum very-low-density lipoprotein triglyceride (TG) levels and hepatic TG synthesis through up-regulation of the expression and activity of sterol regulatory element binding protein 1c (SREBP-1c) [7], a major insulin-responsive regulator of hepatic and adipose tissue lipogenesis. Over-expression of human ORP1L in mouse macrophages resulted in impaired cholesterol efflux and increased size of atherosclerotic lesions in low-density lipoprotein (LDL)-receptor deficient mice [8]. Furthermore, our latest data demonstrates a role of the OSBP homologue ORP8 as factor that suppresses, most likely via an indirect mechanism, the expression of ATP-binding cassette transporter A1 (ABCA1) [9], a key mediator of high-density lipoprotein (HDL) biogenesis. Moreover, ORP2, ORP4S, and ORP9 have been implicated in cellular sterol or neutral lipid metabolism [10-12], lending further support to the view that ORP family members play important roles in cellular lipid metabolism.
###end p 7
###begin p 8
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL2</italic>
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL9</italic>
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 550 557 550 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 663 668 <span type="species:ncbi:9606">human</span>
In the present study, we assessed whether allelic diversity of the OSBPL2, OSBPL9, or OSBPL10 genes contributes to extreme serum lipid levels in Finnish families ascertained for low HDL-cholesterol or familial combined hyperlipidemia (FCHL, common dyslipidemias associated with increased risk of premature coronary heart disease [13-16]. Variants of OSBPL10 displayed suggestive linkage with high triglyceride levels in the families, and association analysis in a metabolic syndrome study sample (N = 2,138) strengthened the notion that variation in OSBPL10 may influence serum TG levels in Finnish dyslipidemic subjects. RNA interference experiments in cultured human hepatoma cells suggested that the encoded protein, ORP10, acts as a regulator of cellular lipid biosyntheses and apolipoprotein B-100 (apoB100) secretion, lending functional support to the genetic findings.
###end p 8
###begin title 9
Materials and methods
###end title 9
###begin title 10
Dyslipidemic cohorts and genotyping strategy
###end title 10
###begin p 11
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM3">1</xref>
###xml 859 913 859 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">Electronic Supplementary Materials method descriptions</xref>
###xml 1014 1015 1014 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM2">1</xref>
###xml 1028 1029 1028 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1031 1038 1031 1038 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1038 1102 1038 1102 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="12">Phenotypic characteristics of the low-HDL and FCHL study samples</p>
###xml 1038 1102 1038 1102 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="12">Phenotypic characteristics of the low-HDL and FCHL study samples</p></caption>
###xml 1102 1102 1102 1102 <th xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1102 1107 1102 1107 <th xmlns:xlink="http://www.w3.org/1999/xlink">Trait</th>
###xml 1107 1112 1107 1112 <th xmlns:xlink="http://www.w3.org/1999/xlink">Males</th>
###xml 1112 1119 1112 1119 <th xmlns:xlink="http://www.w3.org/1999/xlink">Females</th>
###xml 1119 1124 1119 1124 <th xmlns:xlink="http://www.w3.org/1999/xlink">Total</th>
###xml 1102 1124 1102 1124 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th/><th>Trait</th><th>Males</th><th>Females</th><th>Total</th></tr>
###xml 1102 1124 1102 1124 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th/><th>Trait</th><th>Males</th><th>Females</th><th>Total</th></tr></thead>
###xml 1124 1131 1124 1131 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="6">Low-HDL</td>
###xml 1131 1132 1131 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1131 1132 1131 1132 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>N</italic></td>
###xml 1132 1135 1132 1135 <td xmlns:xlink="http://www.w3.org/1999/xlink">327</td>
###xml 1135 1138 1135 1138 <td xmlns:xlink="http://www.w3.org/1999/xlink">338</td>
###xml 1138 1141 1138 1141 <td xmlns:xlink="http://www.w3.org/1999/xlink">665</td>
###xml 1124 1141 1124 1141 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="6">Low-HDL</td><td><italic>N</italic></td><td>327</td><td>338</td><td>665</td></tr>
###xml 1144 1145 1144 1145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1141 1153 1141 1153 <td xmlns:xlink="http://www.w3.org/1999/xlink">Age<sup>a</sup> (years)</td>
###xml 1153 1168 1153 1166 <td xmlns:xlink="http://www.w3.org/1999/xlink">45.30&#8201;&#177;&#8201;22.08</td>
###xml 1168 1182 1166 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink">45.61&#8201;&#177;&#8201;20.5</td>
###xml 1182 1196 1178 1190 <td xmlns:xlink="http://www.w3.org/1999/xlink">45.47&#8201;&#177;&#8201;21.2</td>
###xml 1141 1196 1141 1190 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Age<sup>a</sup> (years)</td><td>45.30&#8201;&#177;&#8201;22.08</td><td>45.61&#8201;&#177;&#8201;20.5</td><td>45.47&#8201;&#177;&#8201;21.2</td></tr>
###xml 1205 1206 1199 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1196 1207 1190 1201 <td xmlns:xlink="http://www.w3.org/1999/xlink">BMI (kg/m<sup>2</sup>)</td>
###xml 1207 1221 1201 1213 <td xmlns:xlink="http://www.w3.org/1999/xlink">25.47&#8201;&#177;&#8201;4.25</td>
###xml 1221 1235 1213 1225 <td xmlns:xlink="http://www.w3.org/1999/xlink">24.76&#8201;&#177;&#8201;4.66</td>
###xml 1235 1248 1225 1236 <td xmlns:xlink="http://www.w3.org/1999/xlink">25.09&#8201;&#177;&#8201;4.5</td>
###xml 1196 1248 1190 1236 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>BMI (kg/m<sup>2</sup>)</td><td>25.47&#8201;&#177;&#8201;4.25</td><td>24.76&#8201;&#177;&#8201;4.66</td><td>25.09&#8201;&#177;&#8201;4.5</td></tr>
###xml 1248 1259 1236 1247 <td xmlns:xlink="http://www.w3.org/1999/xlink">TC (mmol/l)</td>
###xml 1259 1272 1247 1258 <td xmlns:xlink="http://www.w3.org/1999/xlink">5,40&#8201;&#177;&#8201;1.16</td>
###xml 1272 1285 1258 1269 <td xmlns:xlink="http://www.w3.org/1999/xlink">5,47&#8201;&#177;&#8201;1.07</td>
###xml 1285 1298 1269 1280 <td xmlns:xlink="http://www.w3.org/1999/xlink">5,44&#8201;&#177;&#8201;1.11</td>
###xml 1248 1298 1236 1280 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>TC (mmol/l)</td><td>5,40&#8201;&#177;&#8201;1.16</td><td>5,47&#8201;&#177;&#8201;1.07</td><td>5,44&#8201;&#177;&#8201;1.11</td></tr>
###xml 1298 1310 1280 1292 <td xmlns:xlink="http://www.w3.org/1999/xlink">HDL (mmol/l)</td>
###xml 1310 1322 1292 1302 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.02&#8201;&#177;&#8201;0.3</td>
###xml 1322 1335 1302 1313 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.35&#8201;&#177;&#8201;0.38</td>
###xml 1335 1348 1313 1324 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.20&#8201;&#177;&#8201;0.38</td>
###xml 1298 1348 1280 1324 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HDL (mmol/l)</td><td>1.02&#8201;&#177;&#8201;0.3</td><td>1.35&#8201;&#177;&#8201;0.38</td><td>1.20&#8201;&#177;&#8201;0.38</td></tr>
###xml 1348 1359 1324 1335 <td xmlns:xlink="http://www.w3.org/1999/xlink">TG (mmol/l)</td>
###xml 1359 1371 1335 1345 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.59&#8201;&#177;&#8201;0.8</td>
###xml 1371 1384 1345 1356 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.45&#8201;&#177;&#8201;0.79</td>
###xml 1384 1396 1356 1366 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.51&#8201;&#177;&#8201;0.8</td>
###xml 1348 1396 1324 1366 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>TG (mmol/l)</td><td>1.59&#8201;&#177;&#8201;0.8</td><td>1.45&#8201;&#177;&#8201;0.79</td><td>1.51&#8201;&#177;&#8201;0.8</td></tr>
###xml 1396 1400 1366 1370 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="6">FCHL</td>
###xml 1400 1401 1370 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1400 1401 1370 1371 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>N</italic></td>
###xml 1401 1404 1371 1374 <td xmlns:xlink="http://www.w3.org/1999/xlink">687</td>
###xml 1404 1407 1374 1377 <td xmlns:xlink="http://www.w3.org/1999/xlink">632</td>
###xml 1407 1412 1377 1382 <td xmlns:xlink="http://www.w3.org/1999/xlink">1,319</td>
###xml 1396 1412 1366 1382 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="6">FCHL</td><td><italic>N</italic></td><td>687</td><td>632</td><td>1,319</td></tr>
###xml 1412 1423 1382 1393 <td xmlns:xlink="http://www.w3.org/1999/xlink">Age (years)</td>
###xml 1423 1438 1393 1406 <td xmlns:xlink="http://www.w3.org/1999/xlink">37.60&#8201;&#177;&#8201;20.44</td>
###xml 1438 1453 1406 1419 <td xmlns:xlink="http://www.w3.org/1999/xlink">37.91&#8201;&#177;&#8201;20.35</td>
###xml 1453 1466 1419 1430 <td xmlns:xlink="http://www.w3.org/1999/xlink">37.7&#8201;&#177;&#8201;20.4</td>
###xml 1412 1466 1382 1430 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Age (years)</td><td>37.60&#8201;&#177;&#8201;20.44</td><td>37.91&#8201;&#177;&#8201;20.35</td><td>37.7&#8201;&#177;&#8201;20.4</td></tr>
###xml 1475 1476 1439 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1466 1477 1430 1441 <td xmlns:xlink="http://www.w3.org/1999/xlink">BMI (kg/m<sup>2</sup>)</td>
###xml 1477 1491 1441 1453 <td xmlns:xlink="http://www.w3.org/1999/xlink">25.56&#8201;&#177;&#8201;4.46</td>
###xml 1491 1505 1453 1465 <td xmlns:xlink="http://www.w3.org/1999/xlink">24.90&#8201;&#177;&#8201;5.29</td>
###xml 1505 1519 1465 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink">25.22&#8201;&#177;&#8201;5.02</td>
###xml 1466 1519 1430 1477 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>BMI (kg/m<sup>2</sup>)</td><td>25.56&#8201;&#177;&#8201;4.46</td><td>24.90&#8201;&#177;&#8201;5.29</td><td>25.22&#8201;&#177;&#8201;5.02</td></tr>
###xml 1519 1530 1477 1488 <td xmlns:xlink="http://www.w3.org/1999/xlink">TC (mmol/l)</td>
###xml 1530 1543 1488 1499 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.84&#8201;&#177;&#8201;1.43</td>
###xml 1543 1556 1499 1510 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.85&#8201;&#177;&#8201;1.32</td>
###xml 1556 1569 1510 1521 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.84&#8201;&#177;&#8201;1.37</td>
###xml 1519 1569 1477 1521 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>TC (mmol/l)</td><td>5.84&#8201;&#177;&#8201;1.43</td><td>5.85&#8201;&#177;&#8201;1.32</td><td>5.84&#8201;&#177;&#8201;1.37</td></tr>
###xml 1569 1581 1521 1533 <td xmlns:xlink="http://www.w3.org/1999/xlink">HDL (mmol/l)</td>
###xml 1581 1594 1533 1544 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.15&#8201;&#177;&#8201;0.36</td>
###xml 1594 1607 1544 1555 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.39&#8201;&#177;&#8201;0.41</td>
###xml 1607 1620 1555 1566 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.27&#8201;&#177;&#8201;0.41</td>
###xml 1569 1620 1521 1566 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HDL (mmol/l)</td><td>1.15&#8201;&#177;&#8201;0.36</td><td>1.39&#8201;&#177;&#8201;0.41</td><td>1.27&#8201;&#177;&#8201;0.41</td></tr>
###xml 1620 1631 1566 1577 <td xmlns:xlink="http://www.w3.org/1999/xlink">TG (mmol/l)</td>
###xml 1631 1644 1577 1588 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.11&#8201;&#177;&#8201;1.88</td>
###xml 1644 1657 1588 1599 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.59&#8201;&#177;&#8201;1.27</td>
###xml 1657 1669 1599 1609 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.85&#8201;&#177;&#8201;1.6</td>
###xml 1620 1669 1566 1609 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>TG (mmol/l)</td><td>2.11&#8201;&#177;&#8201;1.88</td><td>1.59&#8201;&#177;&#8201;1.27</td><td>1.85&#8201;&#177;&#8201;1.6</td></tr>
###xml 1124 1669 1124 1609 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td rowspan="6">Low-HDL</td><td><italic>N</italic></td><td>327</td><td>338</td><td>665</td></tr><tr><td>Age<sup>a</sup> (years)</td><td>45.30&#8201;&#177;&#8201;22.08</td><td>45.61&#8201;&#177;&#8201;20.5</td><td>45.47&#8201;&#177;&#8201;21.2</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.47&#8201;&#177;&#8201;4.25</td><td>24.76&#8201;&#177;&#8201;4.66</td><td>25.09&#8201;&#177;&#8201;4.5</td></tr><tr><td>TC (mmol/l)</td><td>5,40&#8201;&#177;&#8201;1.16</td><td>5,47&#8201;&#177;&#8201;1.07</td><td>5,44&#8201;&#177;&#8201;1.11</td></tr><tr><td>HDL (mmol/l)</td><td>1.02&#8201;&#177;&#8201;0.3</td><td>1.35&#8201;&#177;&#8201;0.38</td><td>1.20&#8201;&#177;&#8201;0.38</td></tr><tr><td>TG (mmol/l)</td><td>1.59&#8201;&#177;&#8201;0.8</td><td>1.45&#8201;&#177;&#8201;0.79</td><td>1.51&#8201;&#177;&#8201;0.8</td></tr><tr><td rowspan="6">FCHL</td><td><italic>N</italic></td><td>687</td><td>632</td><td>1,319</td></tr><tr><td>Age (years)</td><td>37.60&#8201;&#177;&#8201;20.44</td><td>37.91&#8201;&#177;&#8201;20.35</td><td>37.7&#8201;&#177;&#8201;20.4</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.56&#8201;&#177;&#8201;4.46</td><td>24.90&#8201;&#177;&#8201;5.29</td><td>25.22&#8201;&#177;&#8201;5.02</td></tr><tr><td>TC (mmol/l)</td><td>5.84&#8201;&#177;&#8201;1.43</td><td>5.85&#8201;&#177;&#8201;1.32</td><td>5.84&#8201;&#177;&#8201;1.37</td></tr><tr><td>HDL (mmol/l)</td><td>1.15&#8201;&#177;&#8201;0.36</td><td>1.39&#8201;&#177;&#8201;0.41</td><td>1.27&#8201;&#177;&#8201;0.41</td></tr><tr><td>TG (mmol/l)</td><td>2.11&#8201;&#177;&#8201;1.88</td><td>1.59&#8201;&#177;&#8201;1.27</td><td>1.85&#8201;&#177;&#8201;1.6</td></tr></tbody>
###xml 1102 1669 1102 1609 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th/><th>Trait</th><th>Males</th><th>Females</th><th>Total</th></tr></thead><tbody><tr><td rowspan="6">Low-HDL</td><td><italic>N</italic></td><td>327</td><td>338</td><td>665</td></tr><tr><td>Age<sup>a</sup> (years)</td><td>45.30&#8201;&#177;&#8201;22.08</td><td>45.61&#8201;&#177;&#8201;20.5</td><td>45.47&#8201;&#177;&#8201;21.2</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.47&#8201;&#177;&#8201;4.25</td><td>24.76&#8201;&#177;&#8201;4.66</td><td>25.09&#8201;&#177;&#8201;4.5</td></tr><tr><td>TC (mmol/l)</td><td>5,40&#8201;&#177;&#8201;1.16</td><td>5,47&#8201;&#177;&#8201;1.07</td><td>5,44&#8201;&#177;&#8201;1.11</td></tr><tr><td>HDL (mmol/l)</td><td>1.02&#8201;&#177;&#8201;0.3</td><td>1.35&#8201;&#177;&#8201;0.38</td><td>1.20&#8201;&#177;&#8201;0.38</td></tr><tr><td>TG (mmol/l)</td><td>1.59&#8201;&#177;&#8201;0.8</td><td>1.45&#8201;&#177;&#8201;0.79</td><td>1.51&#8201;&#177;&#8201;0.8</td></tr><tr><td rowspan="6">FCHL</td><td><italic>N</italic></td><td>687</td><td>632</td><td>1,319</td></tr><tr><td>Age (years)</td><td>37.60&#8201;&#177;&#8201;20.44</td><td>37.91&#8201;&#177;&#8201;20.35</td><td>37.7&#8201;&#177;&#8201;20.4</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.56&#8201;&#177;&#8201;4.46</td><td>24.90&#8201;&#177;&#8201;5.29</td><td>25.22&#8201;&#177;&#8201;5.02</td></tr><tr><td>TC (mmol/l)</td><td>5.84&#8201;&#177;&#8201;1.43</td><td>5.85&#8201;&#177;&#8201;1.32</td><td>5.84&#8201;&#177;&#8201;1.37</td></tr><tr><td>HDL (mmol/l)</td><td>1.15&#8201;&#177;&#8201;0.36</td><td>1.39&#8201;&#177;&#8201;0.41</td><td>1.27&#8201;&#177;&#8201;0.41</td></tr><tr><td>TG (mmol/l)</td><td>2.11&#8201;&#177;&#8201;1.88</td><td>1.59&#8201;&#177;&#8201;1.27</td><td>1.85&#8201;&#177;&#8201;1.6</td></tr></tbody></table>
###xml 1669 1699 1609 1637 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="13">The data represent mean &#177; SD</p>
###xml 1699 1702 1637 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMI</italic>
###xml 1720 1722 1658 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TC</italic>
###xml 1742 1745 1680 1683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HDL</italic>
###xml 1784 1786 1722 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TG</italic>
###xml 1699 1800 1637 1738 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="14"><italic>BMI</italic> body mass index, <italic>TC</italic> total cholesterol, <italic>HDL</italic> high-density lipoprotein cholesterol, <italic>TG</italic> triglycerides</p>
###xml 1800 1801 1738 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1800 1849 1738 1787 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="15"><sup>a</sup>Subjects under the age of 20&#160;years were excluded</p>
###xml 1669 1849 1609 1787 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="13">The data represent mean &#177; SD</p><p textid="14"><italic>BMI</italic> body mass index, <italic>TC</italic> total cholesterol, <italic>HDL</italic> high-density lipoprotein cholesterol, <italic>TG</italic> triglycerides</p><p textid="15"><sup>a</sup>Subjects under the age of 20&#160;years were excluded</p></table-wrap-foot>
###xml 1031 1849 1031 1787 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="12">Phenotypic characteristics of the low-HDL and FCHL study samples</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Trait</th><th>Males</th><th>Females</th><th>Total</th></tr></thead><tbody><tr><td rowspan="6">Low-HDL</td><td><italic>N</italic></td><td>327</td><td>338</td><td>665</td></tr><tr><td>Age<sup>a</sup> (years)</td><td>45.30&#8201;&#177;&#8201;22.08</td><td>45.61&#8201;&#177;&#8201;20.5</td><td>45.47&#8201;&#177;&#8201;21.2</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.47&#8201;&#177;&#8201;4.25</td><td>24.76&#8201;&#177;&#8201;4.66</td><td>25.09&#8201;&#177;&#8201;4.5</td></tr><tr><td>TC (mmol/l)</td><td>5,40&#8201;&#177;&#8201;1.16</td><td>5,47&#8201;&#177;&#8201;1.07</td><td>5,44&#8201;&#177;&#8201;1.11</td></tr><tr><td>HDL (mmol/l)</td><td>1.02&#8201;&#177;&#8201;0.3</td><td>1.35&#8201;&#177;&#8201;0.38</td><td>1.20&#8201;&#177;&#8201;0.38</td></tr><tr><td>TG (mmol/l)</td><td>1.59&#8201;&#177;&#8201;0.8</td><td>1.45&#8201;&#177;&#8201;0.79</td><td>1.51&#8201;&#177;&#8201;0.8</td></tr><tr><td rowspan="6">FCHL</td><td><italic>N</italic></td><td>687</td><td>632</td><td>1,319</td></tr><tr><td>Age (years)</td><td>37.60&#8201;&#177;&#8201;20.44</td><td>37.91&#8201;&#177;&#8201;20.35</td><td>37.7&#8201;&#177;&#8201;20.4</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.56&#8201;&#177;&#8201;4.46</td><td>24.90&#8201;&#177;&#8201;5.29</td><td>25.22&#8201;&#177;&#8201;5.02</td></tr><tr><td>TC (mmol/l)</td><td>5.84&#8201;&#177;&#8201;1.43</td><td>5.85&#8201;&#177;&#8201;1.32</td><td>5.84&#8201;&#177;&#8201;1.37</td></tr><tr><td>HDL (mmol/l)</td><td>1.15&#8201;&#177;&#8201;0.36</td><td>1.39&#8201;&#177;&#8201;0.41</td><td>1.27&#8201;&#177;&#8201;0.41</td></tr><tr><td>TG (mmol/l)</td><td>2.11&#8201;&#177;&#8201;1.88</td><td>1.59&#8201;&#177;&#8201;1.27</td><td>1.85&#8201;&#177;&#8201;1.6</td></tr></tbody></table><table-wrap-foot><p textid="13">The data represent mean &#177; SD</p><p textid="14"><italic>BMI</italic> body mass index, <italic>TC</italic> total cholesterol, <italic>HDL</italic> high-density lipoprotein cholesterol, <italic>TG</italic> triglycerides</p><p textid="15"><sup>a</sup>Subjects under the age of 20&#160;years were excluded</p></table-wrap-foot></table-wrap>
###xml 1849 1855 1787 1793 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1938 1945 1876 1883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 2069 2093 2007 2031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below the gene structure</italic>
###xml 2184 2187 2122 2125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 2247 2253 2185 2191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 2273 2274 2211 2212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 2274 2275 2212 2213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2281 2284 2219 2222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 2306 2312 2244 2250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 2379 2380 2317 2318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2441 2447 2379 2385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in red</italic>
###xml 2449 2473 2387 2411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above the gene structure</italic>
###xml 1855 2473 1793 2411 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="16">Location and linkage disequilibrium (LD) relationships of the investigated SNPs in <italic>OSBPL10</italic>. Exons 1&#8211;13 as well as introns 2 and 5 are indicated. The SNPs analyzed in the low-HDL and FCHL family materials are shown <italic>below the gene structure</italic>; those with the highest LOD scores (&gt;2.0) for linkage with high-TG trait are indicated in <italic>red</italic>. The LD relationships between the SNPs are depicted at the <italic>bottom</italic>; Numbers represent <italic>r</italic><sup>2</sup>, the <italic>top</italic> one for FCHL and the <italic>bottom</italic> one for low-HDL families. The SNPs showing strongest association (<italic>p</italic>&#8201;&lt;&#8201;0.01) with high TG in the Genmets data set are displayed (<italic>in red</italic>) <italic>above the gene structure</italic></p>
###xml 1855 2473 1793 2411 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="16">Location and linkage disequilibrium (LD) relationships of the investigated SNPs in <italic>OSBPL10</italic>. Exons 1&#8211;13 as well as introns 2 and 5 are indicated. The SNPs analyzed in the low-HDL and FCHL family materials are shown <italic>below the gene structure</italic>; those with the highest LOD scores (&gt;2.0) for linkage with high-TG trait are indicated in <italic>red</italic>. The LD relationships between the SNPs are depicted at the <italic>bottom</italic>; Numbers represent <italic>r</italic><sup>2</sup>, the <italic>top</italic> one for FCHL and the <italic>bottom</italic> one for low-HDL families. The SNPs showing strongest association (<italic>p</italic>&#8201;&lt;&#8201;0.01) with high TG in the Genmets data set are displayed (<italic>in red</italic>) <italic>above the gene structure</italic></p></caption>
###xml 2473 2473 2411 2411 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_490_Fig1_HTML" id="MO1"/>
###xml 1849 2473 1787 2411 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="16">Location and linkage disequilibrium (LD) relationships of the investigated SNPs in <italic>OSBPL10</italic>. Exons 1&#8211;13 as well as introns 2 and 5 are indicated. The SNPs analyzed in the low-HDL and FCHL family materials are shown <italic>below the gene structure</italic>; those with the highest LOD scores (&gt;2.0) for linkage with high-TG trait are indicated in <italic>red</italic>. The LD relationships between the SNPs are depicted at the <italic>bottom</italic>; Numbers represent <italic>r</italic><sup>2</sup>, the <italic>top</italic> one for FCHL and the <italic>bottom</italic> one for low-HDL families. The SNPs showing strongest association (<italic>p</italic>&#8201;&lt;&#8201;0.01) with high TG in the Genmets data set are displayed (<italic>in red</italic>) <italic>above the gene structure</italic></p></caption><graphic position="anchor" xlink:href="109_2009_490_Fig1_HTML" id="MO1"/></fig>
The FCHL families (53 families, 684 subjects) were recruited through the Helsinki, Turku, and Kuopio University Central Hospitals and the inclusion/exclusion criteria for the probands have been described [17]. The low-HDL families (39 families, 426 subjects) were collected in the Helsinki and Turku University Hospitals, and probands were required to have HDL-cholesterol (HDL-C) levels <10th age- and sex-specific percentile of the Finnish population and angiographically verified coronary heart disease and are more fully described in [18]. Phenotypic information on the study subjects and the distributions of their serum HDL-C and TG concentrations are displayed in Table 1 and in Electronic Supplementary Materials Fig. 1, respectively. DNA extraction, single-nucleotide polymorphism (SNP) genotyping, and data analysis were carried out as described in Electronic Supplementary Materials method descriptions. Detailed information on the SNPs analyzed is displayed in Electronic Supplementary Materials Table 1 and in Fig. 1. Table 1Phenotypic characteristics of the low-HDL and FCHL study samplesTraitMalesFemalesTotalLow-HDLN327338665Agea (years)45.30 +/- 22.0845.61 +/- 20.545.47 +/- 21.2BMI (kg/m2)25.47 +/- 4.2524.76 +/- 4.6625.09 +/- 4.5TC (mmol/l)5,40 +/- 1.165,47 +/- 1.075,44 +/- 1.11HDL (mmol/l)1.02 +/- 0.31.35 +/- 0.381.20 +/- 0.38TG (mmol/l)1.59 +/- 0.81.45 +/- 0.791.51 +/- 0.8FCHLN6876321,319Age (years)37.60 +/- 20.4437.91 +/- 20.3537.7 +/- 20.4BMI (kg/m2)25.56 +/- 4.4624.90 +/- 5.2925.22 +/- 5.02TC (mmol/l)5.84 +/- 1.435.85 +/- 1.325.84 +/- 1.37HDL (mmol/l)1.15 +/- 0.361.39 +/- 0.411.27 +/- 0.41TG (mmol/l)2.11 +/- 1.881.59 +/- 1.271.85 +/- 1.6The data represent mean +/- SDBMI body mass index, TC total cholesterol, HDL high-density lipoprotein cholesterol, TG triglyceridesaSubjects under the age of 20 years were excludedFig. 1Location and linkage disequilibrium (LD) relationships of the investigated SNPs in OSBPL10. Exons 1-13 as well as introns 2 and 5 are indicated. The SNPs analyzed in the low-HDL and FCHL family materials are shown below the gene structure; those with the highest LOD scores (>2.0) for linkage with high-TG trait are indicated in red. The LD relationships between the SNPs are depicted at the bottom; Numbers represent r2, the top one for FCHL and the bottom one for low-HDL families. The SNPs showing strongest association (p < 0.01) with high TG in the Genmets data set are displayed (in red) above the gene structure
###end p 11
###begin p 12
Phenotypic characteristics of the low-HDL and FCHL study samples
###end p 12
###begin p 13
The data represent mean +/- SD
###end p 13
###begin p 14
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMI</italic>
###xml 21 23 21 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TC</italic>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HDL</italic>
###xml 85 87 85 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TG</italic>
BMI body mass index, TC total cholesterol, HDL high-density lipoprotein cholesterol, TG triglycerides
###end p 14
###begin p 15
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aSubjects under the age of 20 years were excluded
###end p 15
###begin p 16
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 214 238 214 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below the gene structure</italic>
###xml 329 332 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 418 419 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 419 420 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 451 457 451 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 586 592 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in red</italic>
###xml 594 618 594 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above the gene structure</italic>
Location and linkage disequilibrium (LD) relationships of the investigated SNPs in OSBPL10. Exons 1-13 as well as introns 2 and 5 are indicated. The SNPs analyzed in the low-HDL and FCHL family materials are shown below the gene structure; those with the highest LOD scores (>2.0) for linkage with high-TG trait are indicated in red. The LD relationships between the SNPs are depicted at the bottom; Numbers represent r2, the top one for FCHL and the bottom one for low-HDL families. The SNPs showing strongest association (p < 0.01) with high TG in the Genmets data set are displayed (in red) above the gene structure
###end p 16
###begin p 17
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 746 800 746 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">Electronic Supplementary Materials method descriptions</xref>
The Genmets sample is subset of 2,212 individuals of the Health2000 study () collected as metabolic syndrome cases and their matched controls. A total of 2,173 of these individuals have been genotyped on Illumina 610K arrays. In this study, 102 SNPs located in OSBPL10 or its flanking regions were analyzed. For the association analysis, individuals with the TG levels above the 95th population, sex, and age-specific percentile (>3.4 mmol/l) were coded as cases and the rest as controls. The same coding was done for the individuals with the high-density lipoprotein cholesterol values below the 5th percentile (<0.8 mmol/l). For these two dichotomous phenotypes, logistic regression was applied with age and sex as covariates (for details, see Electronic Supplementary Materials method descriptions).
###end p 17
###begin p 18
The study materials were collected according to the Helsinki declaration, and the ethics committees of the participating centers approved the study design.
###end p 18
###begin title 19
###xml 16 22 <span type="species:ncbi:9986">rabbit</span>
Generation of a rabbit antibody against ORP10
###end title 19
###begin p 20
###xml 189 190 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 221 237 216 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 221 242 <span type="species:ncbi:511693">Escherichia coli BL21</span>
###xml 373 380 <span type="species:ncbi:9986">rabbits</span>
A cDNA fragment encoding amino acid residues 1-80 of the full-length ORP10 protein (NM_017784) was inserted in pGEX1lambdaT (GE Healthcare, Uppsala, Sweden) for production of a glutathione-S-transferase fusion protein in Escherichia coli BL21. The protein was purified on Glutathione-Sepharose 4B (GE Healthcare) and used for subcutaneous immunization of New Zealand white rabbits by a standard procedure.
###end p 20
###begin title 21
Cell culture
###end title 21
###begin p 22
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 176 182 <span type="species:ncbi:9913">bovine</span>
The human hepatoma cell line Huh7 was cultured in Eagle's minimal essential medium with Earle's salts (EMEM, Sigma-Aldrich, St. Louis, MO, USA), 20 mM Hepes, pH 7.4, 10% fetal bovine serum (FBS; Gibco/Invitrogen, Grand Island, NY, USA), 100 U/ml penicillin, and 100 mug/ml streptomycin. The pancreatic adenocarcinoma cell line PANC-1 was cultured in RPMI 1640 (BioWhittaker, Walkersville, MD, USA), 10% FBS, and the above antibiotics. Caco-2 cells were cultured in EMEM supplemented with 10% FBS, non-essential amino acids, and the above antibiotics.
###end p 22
###begin title 23
RNA interference
###end title 23
###begin p 24
Huh7 cells were transfected with ORP10-specific (siORP10.1, sense strand CCACAGCCUCAAUCUUGUAdTdT; siORP10.2, GAGAAUUUCCUGUGGAU-UAdTdT) or nontargeting control siRNA (siNT, sense strand UAGCGACUAAACACAUCAAdTdT) using INTERFERin (Polyplus, Illkirch, France) or HiPerFect (Qiagen, Valencia, CA, USA) according to the manufacturers' instructions. After 48 h transfection, the cells were either subjected to total RNA isolation by using the RNeasy Mini kit (Qiagen) or used for analysis of cholesterol and triglyceride biosynthesis.
###end p 24
###begin title 25
Analysis of cholesterol and triglyceride biosynthesis
###end title 25
###begin p 26
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 224 278 224 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">Electronic Supplementary Materials method descriptions</xref>
Huh7 cells treated with ORP10-specific or nontargeting control siRNAs were labeled with [3H]acetic acid or [3H]oleic acid, and incorporation of the radioactive tracers into cholesterol or TG was carried out, as specified in Electronic Supplementary Materials method descriptions.
###end p 26
###begin title 27
Assays for apoA-I and apoB100 secretion by Huh7 cells
###end title 27
###begin p 28
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
Huh7 cells treated for 48 h with nontargeting or ORP10-specific siRNAs as specified above were washed with phosphate-buffered saline and transferred into serum-free culture medium. The medium and the cells were harvested at 6, 12, and 24 h. The apoA-I [19] and apoB100 (Mabtech, Nacka Strand, Sweden) concentrations in the medium were determined with specific sandwich enzyme-linked immunosorbent assay (ELISA) assays and normalized for total cell protein.
###end p 28
###begin title 29
mRNA quantification
###end title 29
###begin p 30
###xml 233 287 233 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">Electronic Supplementary Materials method descriptions</xref>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM2">2</xref>
Total RNA was isolated from Huh7 cells treated with ORP10 or control siRNAs, and quantitative real-time polymerase chain reaction (PCR) analysis of specific mRNAs was carried out using SYBR-green (Applied Biosystems) as described in Electronic Supplementary Materials method descriptions. The primers used are specified in Electronic Supplementary Materials Table 2.
###end p 30
###begin title 31
Assay for 3-hydroxy-3-methylglutaryl coenzyme A reductase activity
###end title 31
###begin p 32
###xml 222 276 222 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">Electronic Supplementary Materials method descriptions</xref>
Huh7 cells treated with ORP10-specific or control siRNAs as specified above were harvested, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity in total membranes of the cells was assayed as detailed in Electronic Supplementary Materials method descriptions.
###end p 32
###begin title 33
Analysis of the subcellular localization of ORP10
###end title 33
###begin p 34
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 556 610 556 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">Electronic Supplementary Materials method descriptions</xref>
###xml 735 789 735 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">Electronic Supplementary Materials method descriptions</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human ORP10 open reading frame (NM_017784) was subcloned into the pEGFP-C (BD Biosciences Clontech, Palo Alto, CA, USA) or pcDNA4HisMax (Invitrogen) vectors for mammalian cell expression. Huh7, PANC-1, or Caco-2 cells cultured in normal serum-containing growth medium were transfected for 24 h using Lipofectamine 2000 (Invitrogen), fixed with paraformaldehyde and processed for immunofluorescence microscopy essentially as described previously [20]. The immunofluorescence double stainings carried out, and pretreatments of the cells are described in Electronic Supplementary Materials method descriptions. Fluorescence recovery after photobleaching (FRAP) in Huh7 cells transfected with EGFP-ORP10 was carried out as detailed in Electronic Supplementary Materials method descriptions.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
Single-nucleotide polymorphisms in OSBPL10 show suggestive linkage with serum triglyceride levels
###end title 36
###begin p 37
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL</italic>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM3">1</xref>
###xml 415 421 415 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL2</italic>
###xml 424 425 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9</italic>
###xml 432 434 432 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 525 526 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 613 620 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL2</italic>
###xml 924 925 924 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9</italic>
###xml 1033 1034 1033 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1172 1173 1172 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1334 1341 1334 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 1348 1349 1348 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1352 1359 1352 1359 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1359 1474 1359 1474 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">Linkage and association results for the dichotomized HDL-cholesterol and TG traits in the low-HDL and FCHL families</p>
###xml 1359 1474 1359 1474 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38">Linkage and association results for the dichotomized HDL-cholesterol and TG traits in the low-HDL and FCHL families</p></caption>
###xml 1474 1474 1474 1474 <th xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1474 1481 1474 1481 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Low-HDL</th>
###xml 1481 1485 1481 1485 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">FCHL</th>
###xml 1485 1493 1485 1493 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Combined</th>
###xml 1474 1493 1474 1493 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th/><th colspan="2">Low-HDL</th><th colspan="2">FCHL</th><th colspan="2">Combined</th></tr>
###xml 1474 1493 1474 1493 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th/><th colspan="2">Low-HDL</th><th colspan="2">FCHL</th><th colspan="2">Combined</th></tr></thead>
###xml 1497 1506 1497 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(OSBPL10)</italic>
###xml 1493 1506 1493 1506 <td xmlns:xlink="http://www.w3.org/1999/xlink">SNP <italic>(OSBPL10)</italic></td>
###xml 1513 1514 1513 1514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1506 1518 1506 1518 <td xmlns:xlink="http://www.w3.org/1999/xlink">&lt;10th %<sup>a</sup> HDL</td>
###xml 1518 1528 1518 1528 <td xmlns:xlink="http://www.w3.org/1999/xlink">&gt;90th % TG</td>
###xml 1528 1539 1528 1539 <td xmlns:xlink="http://www.w3.org/1999/xlink">&lt;10th % HDL</td>
###xml 1539 1549 1539 1549 <td xmlns:xlink="http://www.w3.org/1999/xlink">&gt;90th % TG</td>
###xml 1549 1560 1549 1560 <td xmlns:xlink="http://www.w3.org/1999/xlink">&lt;10th % HDL</td>
###xml 1560 1570 1560 1570 <td xmlns:xlink="http://www.w3.org/1999/xlink">&gt;90th % TG</td>
###xml 1493 1570 1493 1570 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SNP <italic>(OSBPL10)</italic></td><td>&lt;10th %<sup>a</sup> HDL</td><td>&gt;90th % TG</td><td>&lt;10th % HDL</td><td>&gt;90th % TG</td><td>&lt;10th % HDL</td><td>&gt;90th % TG</td></tr>
###xml 1570 1579 1570 1579 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs9878129</td>
###xml 1587 1588 1587 1588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1579 1588 1579 1588 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.02 (1)<sup>b</sup></td>
###xml 1588 1599 1588 1599 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.07)</td>
###xml 1599 1607 1599 1607 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.25 (1)</td>
###xml 1607 1611 1607 1611 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.78</bold>
###xml 1611 1612 1611 1612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1607 1618 1607 1618 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.78</bold><sup>c</sup>(0.53)</td>
###xml 1618 1629 1618 1629 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.26 (0.24)</td>
###xml 1629 1633 1629 1633 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.71</bold>
###xml 1629 1640 1629 1640 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.71</bold> (0.77)</td>
###xml 1570 1640 1570 1640 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs9878129</td><td>0.02 (1)<sup>b</sup></td><td>0.00 (0.07)</td><td>0.25 (1)</td><td><bold>0.78</bold><sup>c</sup>(0.53)</td><td>0.26 (0.24)</td><td><bold>0.71</bold> (0.77)</td></tr>
###xml 1640 1649 1640 1649 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs9847800</td>
###xml 1649 1660 1649 1660 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.43 (0.22)</td>
###xml 1660 1671 1660 1671 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.15 (0.53)</td>
###xml 1671 1682 1671 1682 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.06 (0.54)</td>
###xml 1682 1686 1682 1686 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1.36</bold>
###xml 1682 1693 1682 1693 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1.36</bold> (0.23)</td>
###xml 1693 1697 1693 1697 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.80</bold>
###xml 1693 1704 1693 1704 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.80</bold> (0.21)</td>
###xml 1704 1708 1704 1708 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2.07</bold>
###xml 1704 1715 1704 1715 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>2.07</bold> (0.50)</td>
###xml 1640 1715 1640 1715 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs9847800</td><td>0.43 (0.22)</td><td>0.15 (0.53)</td><td>0.06 (0.54)</td><td><bold>1.36</bold> (0.23)</td><td><bold>0.80</bold> (0.21)</td><td><bold>2.07</bold> (0.50)</td></tr>
###xml 1715 1724 1715 1724 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs9853939</td>
###xml 1724 1735 1724 1735 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.66 (0.19)</td>
###xml 1735 1746 1735 1746 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.89)</td>
###xml 1746 1757 1746 1757 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.09 (0.49)</td>
###xml 1757 1761 1757 1761 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1.79</bold>
###xml 1757 1768 1757 1768 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1.79</bold> (0.82)</td>
###xml 1768 1772 1768 1772 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.98</bold>
###xml 1768 1779 1768 1779 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.98</bold> (0.21)</td>
###xml 1779 1783 1779 1783 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2.40</bold>
###xml 1779 1787 1779 1787 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>2.40</bold> (1)</td>
###xml 1715 1787 1715 1787 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs9853939</td><td>0.66 (0.19)</td><td>0.00 (0.89)</td><td>0.09 (0.49)</td><td><bold>1.79</bold> (0.82)</td><td><bold>0.98</bold> (0.21)</td><td><bold>2.40</bold> (1)</td></tr>
###xml 1787 1796 1787 1796 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs7644177</td>
###xml 1796 1807 1796 1807 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (0.42)</td>
###xml 1813 1819 1813 1819 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.0005</bold>
###xml 1807 1820 1807 1820 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.18 (<bold>0.0005</bold>)</td>
###xml 1820 1831 1820 1831 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (0.74)</td>
###xml 1831 1842 1831 1842 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.12 (0.64)</td>
###xml 1842 1853 1842 1853 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.23 (0.84)</td>
###xml 1859 1863 1859 1863 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.03</bold>
###xml 1853 1864 1853 1864 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.16 (<bold>0.03</bold>)</td>
###xml 1787 1864 1787 1864 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs7644177</td><td>0.01 (0.42)</td><td>0.18 (<bold>0.0005</bold>)</td><td>0.01 (0.74)</td><td>0.12 (0.64)</td><td>0.23 (0.84)</td><td>0.16 (<bold>0.03</bold>)</td></tr>
###xml 1864 1873 1864 1873 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs6807471</td>
###xml 1873 1884 1873 1884 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.40 (0.92)</td>
###xml 1884 1895 1884 1895 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.69)</td>
###xml 1895 1906 1895 1906 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.54 (0.26)</td>
###xml 1906 1917 1906 1917 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (0.14)</td>
###xml 1917 1928 1917 1928 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.34 (0.44)</td>
###xml 1928 1939 1928 1939 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.39)</td>
###xml 1864 1939 1864 1939 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs6807471</td><td>0.40 (0.92)</td><td>0.00 (0.69)</td><td>0.54 (0.26)</td><td>0.01 (0.14)</td><td>0.34 (0.44)</td><td>0.00 (0.39)</td></tr>
###xml 1939 1948 1939 1948 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs9880436</td>
###xml 1948 1959 1948 1959 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.67)</td>
###xml 1959 1970 1959 1970 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.36 (0.60)</td>
###xml 1970 1981 1970 1981 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.59 (0.07)</td>
###xml 1987 1991 1987 1991 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.03</bold>
###xml 1981 1992 1981 1992 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.50 (<bold>0.03</bold>)</td>
###xml 1992 2003 1992 2003 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.46 (0.33)</td>
###xml 2003 2007 2003 2007 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.80</bold>
###xml 2003 2014 2003 2014 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.80</bold> (0.14)</td>
###xml 1939 2014 1939 2014 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs9880436</td><td>0.00 (0.67)</td><td>0.36 (0.60)</td><td>0.59 (0.07)</td><td>0.50 (<bold>0.03</bold>)</td><td>0.46 (0.33)</td><td><bold>0.80</bold> (0.14)</td></tr>
###xml 2014 2024 2014 2024 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs11709187</td>
###xml 2024 2035 2024 2035 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.16 (0.17)</td>
###xml 2035 2046 2035 2046 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.56)</td>
###xml 2046 2057 2046 2057 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.08 (0.84)</td>
###xml 2063 2067 2063 2067 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.03</bold>
###xml 2057 2068 2057 2068 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.28 (<bold>0.03</bold>)</td>
###xml 2068 2079 2068 2079 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.23 (0.32)</td>
###xml 2079 2090 2079 2090 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.22 (0.08)</td>
###xml 2014 2090 2014 2090 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs11709187</td><td>0.16 (0.17)</td><td>0.00 (0.56)</td><td>0.08 (0.84)</td><td>0.28 (<bold>0.03</bold>)</td><td>0.23 (0.32)</td><td>0.22 (0.08)</td></tr>
###xml 2090 2099 2090 2099 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs2219250</td>
###xml 2099 2107 2099 2107 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.55 (1)</td>
###xml 2107 2118 2107 2118 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.08 (0.75)</td>
###xml 2118 2122 2118 2122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.74</bold>
###xml 2118 2129 2118 2129 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.74</bold> (0.79)</td>
###xml 2129 2140 2129 2140 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.20 (0.88)</td>
###xml 2140 2144 2140 2144 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.94</bold>
###xml 2140 2151 2140 2151 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.94</bold> (0.84)</td>
###xml 2151 2159 2151 2159 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.41 (1)</td>
###xml 2090 2159 2090 2159 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs2219250</td><td>0.55 (1)</td><td>0.08 (0.75)</td><td><bold>0.74</bold> (0.79)</td><td>0.20 (0.88)</td><td><bold>0.94</bold> (0.84)</td><td>0.41 (1)</td></tr>
###xml 2159 2168 2159 2168 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs2045298</td>
###xml 2168 2179 2168 2179 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.04 (0.14)</td>
###xml 2179 2190 2179 2190 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.55)</td>
###xml 2190 2201 2190 2201 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.04 (0.79)</td>
###xml 2207 2211 2207 2211 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.03</bold>
###xml 2201 2212 2201 2212 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.51 (<bold>0.03</bold>)</td>
###xml 2212 2223 2212 2223 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.09 (0.47)</td>
###xml 2223 2234 2223 2234 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.38 (0.07)</td>
###xml 2159 2234 2159 2234 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs2045298</td><td>0.04 (0.14)</td><td>0.00 (0.55)</td><td>0.04 (0.79)</td><td>0.51 (<bold>0.03</bold>)</td><td>0.09 (0.47)</td><td>0.38 (0.07)</td></tr>
###xml 2234 2243 2234 2243 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs2290531</td>
###xml 2243 2253 2243 2253 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.13 (0.6)</td>
###xml 2253 2264 2253 2264 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.02 (0.63)</td>
###xml 2264 2275 2264 2275 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.69)</td>
###xml 2275 2286 2275 2286 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.65 (0.84)</td>
###xml 2286 2297 2286 2297 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.75)</td>
###xml 2297 2301 2297 2301 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1.22</bold>
###xml 2297 2308 2297 2308 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1.22</bold> (0.92)</td>
###xml 2234 2308 2234 2308 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs2290531</td><td>0.13 (0.6)</td><td>0.02 (0.63)</td><td>0.00 (0.69)</td><td>0.65 (0.84)</td><td>0.00 (0.75)</td><td><bold>1.22</bold> (0.92)</td></tr>
###xml 2308 2317 2308 2317 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs6803685</td>
###xml 2317 2328 2317 2328 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.49 (0.32)</td>
###xml 2328 2332 2328 2332 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.77</bold>
###xml 2334 2338 2334 2338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.04</bold>
###xml 2328 2339 2328 2339 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.77</bold> (<bold>0.04</bold>)</td>
###xml 2339 2350 2339 2350 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.03 (0.34)</td>
###xml 2350 2361 2350 2361 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (0.72)</td>
###xml 2361 2372 2361 2372 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.52 (0.20)</td>
###xml 2372 2383 2372 2383 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.10 (0.25)</td>
###xml 2308 2383 2308 2383 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs6803685</td><td>0.49 (0.32)</td><td><bold>0.77</bold> (<bold>0.04</bold>)</td><td>0.03 (0.34)</td><td>0.01 (0.72)</td><td>0.52 (0.20)</td><td>0.10 (0.25)</td></tr>
###xml 2383 2392 2383 2392 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs1869849</td>
###xml 2392 2396 2392 2396 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.72</bold>
###xml 2392 2400 2392 2400 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.72</bold> (1)</td>
###xml 2400 2411 2400 2411 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.35 (0.29)</td>
###xml 2411 2422 2411 2422 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.04 (0.76)</td>
###xml 2422 2433 2422 2433 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.10 (0.11)</td>
###xml 2433 2444 2433 2444 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.52 (0.77)</td>
###xml 2444 2455 2444 2455 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.12 (0.75)</td>
###xml 2383 2455 2383 2455 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs1869849</td><td><bold>0.72</bold> (1)</td><td>0.35 (0.29)</td><td>0.04 (0.76)</td><td>0.10 (0.11)</td><td>0.52 (0.77)</td><td>0.12 (0.75)</td></tr>
###xml 2455 2464 2455 2464 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs2013777</td>
###xml 2464 2475 2464 2475 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.65 (0.53)</td>
###xml 2475 2486 2475 2486 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.92)</td>
###xml 2486 2497 2486 2497 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (0.09)</td>
###xml 2497 2508 2497 2508 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (0.48)</td>
###xml 2508 2519 2508 2519 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.03 (0.21)</td>
###xml 2519 2530 2519 2530 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.05 (0.37)</td>
###xml 2455 2530 2455 2530 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs2013777</td><td>0.65 (0.53)</td><td>0.00 (0.92)</td><td>0.01 (0.09)</td><td>0.01 (0.48)</td><td>0.03 (0.21)</td><td>0.05 (0.37)</td></tr>
###xml 2530 2539 2530 2539 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs3749405</td>
###xml 2539 2543 2539 2543 <bold xmlns:xlink="http://www.w3.org/1999/xlink">0.91</bold>
###xml 2539 2550 2539 2550 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold>0.91</bold> (0.54)</td>
###xml 2550 2561 2550 2561 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.92)</td>
###xml 2561 2572 2561 2572 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (0.14)</td>
###xml 2572 2583 2572 2583 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.01 (0.37)</td>
###xml 2583 2594 2583 2594 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.19)</td>
###xml 2594 2606 2594 2606 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.004 (0.36)</td>
###xml 2530 2606 2530 2606 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs3749405</td><td><bold>0.91</bold> (0.54)</td><td>0.00 (0.92)</td><td>0.01 (0.14)</td><td>0.01 (0.37)</td><td>0.00 (0.19)</td><td>0.004 (0.36)</td></tr>
###xml 2606 2613 2606 2613 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs11058</td>
###xml 2613 2624 2613 2624 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.14)</td>
###xml 2624 2635 2624 2635 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.58)</td>
###xml 2635 2646 2635 2646 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.78)</td>
###xml 2646 2657 2646 2657 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.45 (0.15)</td>
###xml 2657 2668 2657 2668 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00 (0.57)</td>
###xml 2668 2679 2668 2679 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.12 (0.13)</td>
###xml 2606 2679 2606 2679 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs11058</td><td>0.00 (0.14)</td><td>0.00 (0.58)</td><td>0.00 (0.78)</td><td>0.45 (0.15)</td><td>0.00 (0.57)</td><td>0.12 (0.13)</td></tr>
###xml 2679 2680 2679 2680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 2679 2680 2679 2680 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>N</italic></bold>
###xml 2680 2688 2680 2688 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Affected</bold>
###xml 2679 2688 2679 2688 <td xmlns:xlink="http://www.w3.org/1999/xlink"><bold><italic>N</italic></bold><bold>Affected</bold></td>
###xml 2688 2691 2688 2691 <td xmlns:xlink="http://www.w3.org/1999/xlink">167</td>
###xml 2691 2693 2691 2693 <td xmlns:xlink="http://www.w3.org/1999/xlink">46</td>
###xml 2693 2696 2693 2696 <td xmlns:xlink="http://www.w3.org/1999/xlink">255</td>
###xml 2696 2699 2696 2699 <td xmlns:xlink="http://www.w3.org/1999/xlink">205</td>
###xml 2699 2702 2699 2702 <td xmlns:xlink="http://www.w3.org/1999/xlink">422</td>
###xml 2702 2705 2702 2705 <td xmlns:xlink="http://www.w3.org/1999/xlink">251</td>
###xml 2679 2705 2679 2705 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td><bold><italic>N</italic></bold><bold>Affected</bold></td><td>167</td><td>46</td><td>255</td><td>205</td><td>422</td><td>251</td></tr>
###xml 1493 2705 1493 2705 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>SNP <italic>(OSBPL10)</italic></td><td>&lt;10th %<sup>a</sup> HDL</td><td>&gt;90th % TG</td><td>&lt;10th % HDL</td><td>&gt;90th % TG</td><td>&lt;10th % HDL</td><td>&gt;90th % TG</td></tr><tr><td>rs9878129</td><td>0.02 (1)<sup>b</sup></td><td>0.00 (0.07)</td><td>0.25 (1)</td><td><bold>0.78</bold><sup>c</sup>(0.53)</td><td>0.26 (0.24)</td><td><bold>0.71</bold> (0.77)</td></tr><tr><td>rs9847800</td><td>0.43 (0.22)</td><td>0.15 (0.53)</td><td>0.06 (0.54)</td><td><bold>1.36</bold> (0.23)</td><td><bold>0.80</bold> (0.21)</td><td><bold>2.07</bold> (0.50)</td></tr><tr><td>rs9853939</td><td>0.66 (0.19)</td><td>0.00 (0.89)</td><td>0.09 (0.49)</td><td><bold>1.79</bold> (0.82)</td><td><bold>0.98</bold> (0.21)</td><td><bold>2.40</bold> (1)</td></tr><tr><td>rs7644177</td><td>0.01 (0.42)</td><td>0.18 (<bold>0.0005</bold>)</td><td>0.01 (0.74)</td><td>0.12 (0.64)</td><td>0.23 (0.84)</td><td>0.16 (<bold>0.03</bold>)</td></tr><tr><td>rs6807471</td><td>0.40 (0.92)</td><td>0.00 (0.69)</td><td>0.54 (0.26)</td><td>0.01 (0.14)</td><td>0.34 (0.44)</td><td>0.00 (0.39)</td></tr><tr><td>rs9880436</td><td>0.00 (0.67)</td><td>0.36 (0.60)</td><td>0.59 (0.07)</td><td>0.50 (<bold>0.03</bold>)</td><td>0.46 (0.33)</td><td><bold>0.80</bold> (0.14)</td></tr><tr><td>rs11709187</td><td>0.16 (0.17)</td><td>0.00 (0.56)</td><td>0.08 (0.84)</td><td>0.28 (<bold>0.03</bold>)</td><td>0.23 (0.32)</td><td>0.22 (0.08)</td></tr><tr><td>rs2219250</td><td>0.55 (1)</td><td>0.08 (0.75)</td><td><bold>0.74</bold> (0.79)</td><td>0.20 (0.88)</td><td><bold>0.94</bold> (0.84)</td><td>0.41 (1)</td></tr><tr><td>rs2045298</td><td>0.04 (0.14)</td><td>0.00 (0.55)</td><td>0.04 (0.79)</td><td>0.51 (<bold>0.03</bold>)</td><td>0.09 (0.47)</td><td>0.38 (0.07)</td></tr><tr><td>rs2290531</td><td>0.13 (0.6)</td><td>0.02 (0.63)</td><td>0.00 (0.69)</td><td>0.65 (0.84)</td><td>0.00 (0.75)</td><td><bold>1.22</bold> (0.92)</td></tr><tr><td>rs6803685</td><td>0.49 (0.32)</td><td><bold>0.77</bold> (<bold>0.04</bold>)</td><td>0.03 (0.34)</td><td>0.01 (0.72)</td><td>0.52 (0.20)</td><td>0.10 (0.25)</td></tr><tr><td>rs1869849</td><td><bold>0.72</bold> (1)</td><td>0.35 (0.29)</td><td>0.04 (0.76)</td><td>0.10 (0.11)</td><td>0.52 (0.77)</td><td>0.12 (0.75)</td></tr><tr><td>rs2013777</td><td>0.65 (0.53)</td><td>0.00 (0.92)</td><td>0.01 (0.09)</td><td>0.01 (0.48)</td><td>0.03 (0.21)</td><td>0.05 (0.37)</td></tr><tr><td>rs3749405</td><td><bold>0.91</bold> (0.54)</td><td>0.00 (0.92)</td><td>0.01 (0.14)</td><td>0.01 (0.37)</td><td>0.00 (0.19)</td><td>0.004 (0.36)</td></tr><tr><td>rs11058</td><td>0.00 (0.14)</td><td>0.00 (0.58)</td><td>0.00 (0.78)</td><td>0.45 (0.15)</td><td>0.00 (0.57)</td><td>0.12 (0.13)</td></tr><tr><td><bold><italic>N</italic></bold><bold>Affected</bold></td><td>167</td><td>46</td><td>255</td><td>205</td><td>422</td><td>251</td></tr></tbody>
###xml 1474 2705 1474 2705 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">Low-HDL</th><th colspan="2">FCHL</th><th colspan="2">Combined</th></tr></thead><tbody><tr><td>SNP <italic>(OSBPL10)</italic></td><td>&lt;10th %<sup>a</sup> HDL</td><td>&gt;90th % TG</td><td>&lt;10th % HDL</td><td>&gt;90th % TG</td><td>&lt;10th % HDL</td><td>&gt;90th % TG</td></tr><tr><td>rs9878129</td><td>0.02 (1)<sup>b</sup></td><td>0.00 (0.07)</td><td>0.25 (1)</td><td><bold>0.78</bold><sup>c</sup>(0.53)</td><td>0.26 (0.24)</td><td><bold>0.71</bold> (0.77)</td></tr><tr><td>rs9847800</td><td>0.43 (0.22)</td><td>0.15 (0.53)</td><td>0.06 (0.54)</td><td><bold>1.36</bold> (0.23)</td><td><bold>0.80</bold> (0.21)</td><td><bold>2.07</bold> (0.50)</td></tr><tr><td>rs9853939</td><td>0.66 (0.19)</td><td>0.00 (0.89)</td><td>0.09 (0.49)</td><td><bold>1.79</bold> (0.82)</td><td><bold>0.98</bold> (0.21)</td><td><bold>2.40</bold> (1)</td></tr><tr><td>rs7644177</td><td>0.01 (0.42)</td><td>0.18 (<bold>0.0005</bold>)</td><td>0.01 (0.74)</td><td>0.12 (0.64)</td><td>0.23 (0.84)</td><td>0.16 (<bold>0.03</bold>)</td></tr><tr><td>rs6807471</td><td>0.40 (0.92)</td><td>0.00 (0.69)</td><td>0.54 (0.26)</td><td>0.01 (0.14)</td><td>0.34 (0.44)</td><td>0.00 (0.39)</td></tr><tr><td>rs9880436</td><td>0.00 (0.67)</td><td>0.36 (0.60)</td><td>0.59 (0.07)</td><td>0.50 (<bold>0.03</bold>)</td><td>0.46 (0.33)</td><td><bold>0.80</bold> (0.14)</td></tr><tr><td>rs11709187</td><td>0.16 (0.17)</td><td>0.00 (0.56)</td><td>0.08 (0.84)</td><td>0.28 (<bold>0.03</bold>)</td><td>0.23 (0.32)</td><td>0.22 (0.08)</td></tr><tr><td>rs2219250</td><td>0.55 (1)</td><td>0.08 (0.75)</td><td><bold>0.74</bold> (0.79)</td><td>0.20 (0.88)</td><td><bold>0.94</bold> (0.84)</td><td>0.41 (1)</td></tr><tr><td>rs2045298</td><td>0.04 (0.14)</td><td>0.00 (0.55)</td><td>0.04 (0.79)</td><td>0.51 (<bold>0.03</bold>)</td><td>0.09 (0.47)</td><td>0.38 (0.07)</td></tr><tr><td>rs2290531</td><td>0.13 (0.6)</td><td>0.02 (0.63)</td><td>0.00 (0.69)</td><td>0.65 (0.84)</td><td>0.00 (0.75)</td><td><bold>1.22</bold> (0.92)</td></tr><tr><td>rs6803685</td><td>0.49 (0.32)</td><td><bold>0.77</bold> (<bold>0.04</bold>)</td><td>0.03 (0.34)</td><td>0.01 (0.72)</td><td>0.52 (0.20)</td><td>0.10 (0.25)</td></tr><tr><td>rs1869849</td><td><bold>0.72</bold> (1)</td><td>0.35 (0.29)</td><td>0.04 (0.76)</td><td>0.10 (0.11)</td><td>0.52 (0.77)</td><td>0.12 (0.75)</td></tr><tr><td>rs2013777</td><td>0.65 (0.53)</td><td>0.00 (0.92)</td><td>0.01 (0.09)</td><td>0.01 (0.48)</td><td>0.03 (0.21)</td><td>0.05 (0.37)</td></tr><tr><td>rs3749405</td><td><bold>0.91</bold> (0.54)</td><td>0.00 (0.92)</td><td>0.01 (0.14)</td><td>0.01 (0.37)</td><td>0.00 (0.19)</td><td>0.004 (0.36)</td></tr><tr><td>rs11058</td><td>0.00 (0.14)</td><td>0.00 (0.58)</td><td>0.00 (0.78)</td><td>0.45 (0.15)</td><td>0.00 (0.57)</td><td>0.12 (0.13)</td></tr><tr><td><bold><italic>N</italic></bold><bold>Affected</bold></td><td>167</td><td>46</td><td>255</td><td>205</td><td>422</td><td>251</td></tr></tbody></table>
###xml 2705 2706 2705 2706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2705 2796 2705 2796 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39"><sup>a</sup>The percentiles used to diagnose represent age- and sex-specific population cut-off values</p>
###xml 2796 2797 2796 2797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2876 2877 2876 2877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2796 2914 2796 2914 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><sup>b</sup>The first value represents the LOD score, the number in parentheses represents <italic>p</italic> value for association, given linkage</p>
###xml 2914 2915 2914 2915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2935 2936 2935 2936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2914 2971 2914 2971 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41"><sup>c</sup>LOD scores &gt;0.7 and <italic>p</italic> values &lt;0.05 are indicated in bold</p>
###xml 2705 2971 2705 2971 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39"><sup>a</sup>The percentiles used to diagnose represent age- and sex-specific population cut-off values</p><p textid="40"><sup>b</sup>The first value represents the LOD score, the number in parentheses represents <italic>p</italic> value for association, given linkage</p><p textid="41"><sup>c</sup>LOD scores &gt;0.7 and <italic>p</italic> values &lt;0.05 are indicated in bold</p></table-wrap-foot>
###xml 1352 2971 1352 2971 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="38">Linkage and association results for the dichotomized HDL-cholesterol and TG traits in the low-HDL and FCHL families</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">Low-HDL</th><th colspan="2">FCHL</th><th colspan="2">Combined</th></tr></thead><tbody><tr><td>SNP <italic>(OSBPL10)</italic></td><td>&lt;10th %<sup>a</sup> HDL</td><td>&gt;90th % TG</td><td>&lt;10th % HDL</td><td>&gt;90th % TG</td><td>&lt;10th % HDL</td><td>&gt;90th % TG</td></tr><tr><td>rs9878129</td><td>0.02 (1)<sup>b</sup></td><td>0.00 (0.07)</td><td>0.25 (1)</td><td><bold>0.78</bold><sup>c</sup>(0.53)</td><td>0.26 (0.24)</td><td><bold>0.71</bold> (0.77)</td></tr><tr><td>rs9847800</td><td>0.43 (0.22)</td><td>0.15 (0.53)</td><td>0.06 (0.54)</td><td><bold>1.36</bold> (0.23)</td><td><bold>0.80</bold> (0.21)</td><td><bold>2.07</bold> (0.50)</td></tr><tr><td>rs9853939</td><td>0.66 (0.19)</td><td>0.00 (0.89)</td><td>0.09 (0.49)</td><td><bold>1.79</bold> (0.82)</td><td><bold>0.98</bold> (0.21)</td><td><bold>2.40</bold> (1)</td></tr><tr><td>rs7644177</td><td>0.01 (0.42)</td><td>0.18 (<bold>0.0005</bold>)</td><td>0.01 (0.74)</td><td>0.12 (0.64)</td><td>0.23 (0.84)</td><td>0.16 (<bold>0.03</bold>)</td></tr><tr><td>rs6807471</td><td>0.40 (0.92)</td><td>0.00 (0.69)</td><td>0.54 (0.26)</td><td>0.01 (0.14)</td><td>0.34 (0.44)</td><td>0.00 (0.39)</td></tr><tr><td>rs9880436</td><td>0.00 (0.67)</td><td>0.36 (0.60)</td><td>0.59 (0.07)</td><td>0.50 (<bold>0.03</bold>)</td><td>0.46 (0.33)</td><td><bold>0.80</bold> (0.14)</td></tr><tr><td>rs11709187</td><td>0.16 (0.17)</td><td>0.00 (0.56)</td><td>0.08 (0.84)</td><td>0.28 (<bold>0.03</bold>)</td><td>0.23 (0.32)</td><td>0.22 (0.08)</td></tr><tr><td>rs2219250</td><td>0.55 (1)</td><td>0.08 (0.75)</td><td><bold>0.74</bold> (0.79)</td><td>0.20 (0.88)</td><td><bold>0.94</bold> (0.84)</td><td>0.41 (1)</td></tr><tr><td>rs2045298</td><td>0.04 (0.14)</td><td>0.00 (0.55)</td><td>0.04 (0.79)</td><td>0.51 (<bold>0.03</bold>)</td><td>0.09 (0.47)</td><td>0.38 (0.07)</td></tr><tr><td>rs2290531</td><td>0.13 (0.6)</td><td>0.02 (0.63)</td><td>0.00 (0.69)</td><td>0.65 (0.84)</td><td>0.00 (0.75)</td><td><bold>1.22</bold> (0.92)</td></tr><tr><td>rs6803685</td><td>0.49 (0.32)</td><td><bold>0.77</bold> (<bold>0.04</bold>)</td><td>0.03 (0.34)</td><td>0.01 (0.72)</td><td>0.52 (0.20)</td><td>0.10 (0.25)</td></tr><tr><td>rs1869849</td><td><bold>0.72</bold> (1)</td><td>0.35 (0.29)</td><td>0.04 (0.76)</td><td>0.10 (0.11)</td><td>0.52 (0.77)</td><td>0.12 (0.75)</td></tr><tr><td>rs2013777</td><td>0.65 (0.53)</td><td>0.00 (0.92)</td><td>0.01 (0.09)</td><td>0.01 (0.48)</td><td>0.03 (0.21)</td><td>0.05 (0.37)</td></tr><tr><td>rs3749405</td><td><bold>0.91</bold> (0.54)</td><td>0.00 (0.92)</td><td>0.01 (0.14)</td><td>0.01 (0.37)</td><td>0.00 (0.19)</td><td>0.004 (0.36)</td></tr><tr><td>rs11058</td><td>0.00 (0.14)</td><td>0.00 (0.58)</td><td>0.00 (0.78)</td><td>0.45 (0.15)</td><td>0.00 (0.57)</td><td>0.12 (0.13)</td></tr><tr><td><bold><italic>N</italic></bold><bold>Affected</bold></td><td>167</td><td>46</td><td>255</td><td>205</td><td>422</td><td>251</td></tr></tbody></table><table-wrap-foot><p textid="39"><sup>a</sup>The percentiles used to diagnose represent age- and sex-specific population cut-off values</p><p textid="40"><sup>b</sup>The first value represents the LOD score, the number in parentheses represents <italic>p</italic> value for association, given linkage</p><p textid="41"><sup>c</sup>LOD scores &gt;0.7 and <italic>p</italic> values &lt;0.05 are indicated in bold</p></table-wrap-foot></table-wrap>
We used carefully phenotyped Finnish families ascertained for low HDL or FCHL to investigate the contribution of variation in OSBPL genes to extreme ends of lipid traits. Phenotypic information on the study subjects is summarized in Table 1, and the distributions of HDL and TG measurements used as traits in the genetic analyses are depicted in Electronic Supplementary Materials Fig. 1. Genotyping of tag SNPs of OSBPL2, -9, and -10 in 39 families (N = 426 genotyped individuals) with low-HDL and 53 Finnish FCHL families (N = 684 genotyped individuals) revealed indications of linkage between multiple SNPs in OSBPL10 and the status for high TG, which was treated as an affection status and defined as exceeding the population sex- and age-specific 90th percentile (Table 2). The indications of linkage emerged mostly in the FCHL families. No evidence for linkage or association could be observed for SNPs of OSBPL2 and -9, so they were excluded from further studies (data not shown). Combining the study materials (92 pedigrees, N = 1,110 individuals) increased the linkage logarithm of the odds (LOD) scores for a number of SNP variants with the high-TG trait (Table 2). The strongest evidence for linkage with the high TG trait was observed for SNP variants rs9853939 (LOD 2.40) and rs9847800 (LOD 2.07), located in intron 2 of OSBPL10 (Fig. 1). Table 2Linkage and association results for the dichotomized HDL-cholesterol and TG traits in the low-HDL and FCHL familiesLow-HDLFCHLCombinedSNP (OSBPL10)<10th %a HDL>90th % TG<10th % HDL>90th % TG<10th % HDL>90th % TGrs98781290.02 (1)b0.00 (0.07)0.25 (1)0.78c(0.53)0.26 (0.24)0.71 (0.77)rs98478000.43 (0.22)0.15 (0.53)0.06 (0.54)1.36 (0.23)0.80 (0.21)2.07 (0.50)rs98539390.66 (0.19)0.00 (0.89)0.09 (0.49)1.79 (0.82)0.98 (0.21)2.40 (1)rs76441770.01 (0.42)0.18 (0.0005)0.01 (0.74)0.12 (0.64)0.23 (0.84)0.16 (0.03)rs68074710.40 (0.92)0.00 (0.69)0.54 (0.26)0.01 (0.14)0.34 (0.44)0.00 (0.39)rs98804360.00 (0.67)0.36 (0.60)0.59 (0.07)0.50 (0.03)0.46 (0.33)0.80 (0.14)rs117091870.16 (0.17)0.00 (0.56)0.08 (0.84)0.28 (0.03)0.23 (0.32)0.22 (0.08)rs22192500.55 (1)0.08 (0.75)0.74 (0.79)0.20 (0.88)0.94 (0.84)0.41 (1)rs20452980.04 (0.14)0.00 (0.55)0.04 (0.79)0.51 (0.03)0.09 (0.47)0.38 (0.07)rs22905310.13 (0.6)0.02 (0.63)0.00 (0.69)0.65 (0.84)0.00 (0.75)1.22 (0.92)rs68036850.49 (0.32)0.77 (0.04)0.03 (0.34)0.01 (0.72)0.52 (0.20)0.10 (0.25)rs18698490.72 (1)0.35 (0.29)0.04 (0.76)0.10 (0.11)0.52 (0.77)0.12 (0.75)rs20137770.65 (0.53)0.00 (0.92)0.01 (0.09)0.01 (0.48)0.03 (0.21)0.05 (0.37)rs37494050.91 (0.54)0.00 (0.92)0.01 (0.14)0.01 (0.37)0.00 (0.19)0.004 (0.36)rs110580.00 (0.14)0.00 (0.58)0.00 (0.78)0.45 (0.15)0.00 (0.57)0.12 (0.13)NAffected16746255205422251aThe percentiles used to diagnose represent age- and sex-specific population cut-off valuesbThe first value represents the LOD score, the number in parentheses represents p value for association, given linkagecLOD scores >0.7 and p values <0.05 are indicated in bold
###end p 37
###begin p 38
Linkage and association results for the dichotomized HDL-cholesterol and TG traits in the low-HDL and FCHL families
###end p 38
###begin p 39
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aThe percentiles used to diagnose represent age- and sex-specific population cut-off values
###end p 39
###begin p 40
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
bThe first value represents the LOD score, the number in parentheses represents p value for association, given linkage
###end p 40
###begin p 41
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
cLOD scores >0.7 and p values <0.05 are indicated in bold
###end p 41
###begin p 42
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
We next studied whether the SNP alleles with the best evidence for linkage with the extreme end of TG concentration show correlation with the OSBPL10 mRNA expression level in fat biopsies withdrawn from 47 individuals belonging to the low-HDL and FCHL families, using transcriptome data acquired with Affymetrix U133 Plus 2.0 microarrays. No significant correlation was detected (data not shown), suggesting that rather than affecting the OSBPL10 mRNA levels, the SNPs may be in linkage disequilibrium (LD) with a yet unidentified functional variant.
###end p 42
###begin p 43
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 599 600 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 624 625 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 637 644 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2a</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2b</xref>
###xml 983 990 983 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 1045 1046 1045 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1049 1055 1049 1055 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1070 1077 1070 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 1197 1198 1197 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1224 1228 1224 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axes</italic>
###xml 1253 1254 1253 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1267 1280 1267 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">straight line</italic>
###xml 1305 1306 1305 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1055 1337 1055 1337 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">Association of <italic>OSBPL10</italic> SNPs with high TG (&gt;95th percentile) of low HDL (&lt;5th percentile) in the Genmets study material. Expected and observed <italic>p</italic> values are depicted. The <italic>axes</italic> represent &#8722;log10 of the <italic>p</italic> values, the <italic>straight line</italic> indicating the expected <italic>p</italic> values assuming no association</p>
###xml 1055 1337 1055 1337 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44">Association of <italic>OSBPL10</italic> SNPs with high TG (&gt;95th percentile) of low HDL (&lt;5th percentile) in the Genmets study material. Expected and observed <italic>p</italic> values are depicted. The <italic>axes</italic> represent &#8722;log10 of the <italic>p</italic> values, the <italic>straight line</italic> indicating the expected <italic>p</italic> values assuming no association</p></caption>
###xml 1337 1337 1337 1337 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_490_Fig2_HTML" id="MO2"/>
###xml 1049 1337 1049 1337 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="44">Association of <italic>OSBPL10</italic> SNPs with high TG (&gt;95th percentile) of low HDL (&lt;5th percentile) in the Genmets study material. Expected and observed <italic>p</italic> values are depicted. The <italic>axes</italic> represent &#8722;log10 of the <italic>p</italic> values, the <italic>straight line</italic> indicating the expected <italic>p</italic> values assuming no association</p></caption><graphic position="anchor" xlink:href="109_2009_490_Fig2_HTML" id="MO2"/></fig>
###xml 1337 1344 1337 1344 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 1368 1375 1368 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 1425 1426 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1344 1433 1344 1433 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45">Genmets study material: <italic>OSBPL10</italic> SNPs associated with high TG (&gt;95th percentile), <italic>p</italic>&#8201;&lt;&#8201;0.01</p>
###xml 1344 1433 1344 1433 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="45">Genmets study material: <italic>OSBPL10</italic> SNPs associated with high TG (&gt;95th percentile), <italic>p</italic>&#8201;&lt;&#8201;0.01</p></caption>
###xml 1433 1436 1433 1436 <th xmlns:xlink="http://www.w3.org/1999/xlink">SNP</th>
###xml 1436 1448 1436 1448 <th xmlns:xlink="http://www.w3.org/1999/xlink">Position, bp</th>
###xml 1448 1461 1448 1461 <th xmlns:xlink="http://www.w3.org/1999/xlink">Effect allele</th>
###xml 1461 1482 1461 1482 <th xmlns:xlink="http://www.w3.org/1999/xlink">Effect all. frequency</th>
###xml 1482 1492 1482 1492 <th xmlns:xlink="http://www.w3.org/1999/xlink">Odds ratio</th>
###xml 1492 1499 1492 1499 <th xmlns:xlink="http://www.w3.org/1999/xlink">P-value</th>
###xml 1433 1499 1433 1499 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>SNP</th><th>Position, bp</th><th>Effect allele</th><th>Effect all. frequency</th><th>Odds ratio</th><th>P-value</th></tr>
###xml 1433 1499 1433 1499 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>SNP</th><th>Position, bp</th><th>Effect allele</th><th>Effect all. frequency</th><th>Odds ratio</th><th>P-value</th></tr></thead>
###xml 1499 1509 1499 1509 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs11716163</td>
###xml 1509 1517 1509 1517 <td xmlns:xlink="http://www.w3.org/1999/xlink">31782580</td>
###xml 1517 1518 1517 1518 <td xmlns:xlink="http://www.w3.org/1999/xlink">T</td>
###xml 1518 1524 1518 1524 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.2633</td>
###xml 1524 1529 1524 1529 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.771</td>
###xml 1529 1537 1529 1537 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.000179</td>
###xml 1499 1537 1499 1537 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs11716163</td><td>31782580</td><td>T</td><td char="." align="char">0.2633</td><td char="." align="char">1.771</td><td char="." align="char">0.000179</td></tr>
###xml 1537 1546 1537 1546 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs7653447</td>
###xml 1546 1554 1546 1554 <td xmlns:xlink="http://www.w3.org/1999/xlink">31814139</td>
###xml 1554 1555 1554 1555 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1555 1561 1555 1561 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.3383</td>
###xml 1561 1567 1561 1567 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.5882</td>
###xml 1567 1575 1567 1575 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.001484</td>
###xml 1537 1575 1537 1575 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs7653447</td><td>31814139</td><td>A</td><td char="." align="char">0.3383</td><td char="." align="char">0.5882</td><td char="." align="char">0.001484</td></tr>
###xml 1575 1584 1575 1584 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs2168422</td>
###xml 1584 1592 1584 1592 <td xmlns:xlink="http://www.w3.org/1999/xlink">31779846</td>
###xml 1592 1593 1592 1593 <td xmlns:xlink="http://www.w3.org/1999/xlink">T</td>
###xml 1593 1599 1593 1599 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.2921</td>
###xml 1599 1605 1599 1605 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.5827</td>
###xml 1605 1613 1605 1613 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.002511</td>
###xml 1575 1613 1575 1613 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs2168422</td><td>31779846</td><td>T</td><td char="." align="char">0.2921</td><td char="." align="char">0.5827</td><td char="." align="char">0.002511</td></tr>
###xml 1613 1622 1613 1622 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs9851048</td>
###xml 1622 1630 1622 1630 <td xmlns:xlink="http://www.w3.org/1999/xlink">31806124</td>
###xml 1630 1631 1630 1631 <td xmlns:xlink="http://www.w3.org/1999/xlink">T</td>
###xml 1631 1637 1631 1637 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.3324</td>
###xml 1637 1643 1637 1643 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.6091</td>
###xml 1643 1651 1643 1651 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.003025</td>
###xml 1613 1651 1613 1651 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs9851048</td><td>31806124</td><td>T</td><td char="." align="char">0.3324</td><td char="." align="char">0.6091</td><td char="." align="char">0.003025</td></tr>
###xml 1651 1660 1651 1660 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs7643025</td>
###xml 1660 1668 1660 1668 <td xmlns:xlink="http://www.w3.org/1999/xlink">31814246</td>
###xml 1668 1669 1668 1669 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1669 1675 1669 1675 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.2527</td>
###xml 1675 1681 1675 1681 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.5911</td>
###xml 1681 1689 1681 1689 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.004931</td>
###xml 1651 1689 1651 1689 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs7643025</td><td>31814246</td><td>A</td><td char="." align="char">0.2527</td><td char="." align="char">0.5911</td><td char="." align="char">0.004931</td></tr>
###xml 1689 1699 1689 1699 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs12171283</td>
###xml 1699 1707 1699 1707 <td xmlns:xlink="http://www.w3.org/1999/xlink">31797341</td>
###xml 1707 1708 1707 1708 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 1708 1714 1708 1714 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.2659</td>
###xml 1714 1720 1714 1720 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.6077</td>
###xml 1720 1727 1720 1727 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.00621</td>
###xml 1689 1727 1689 1727 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs12171283</td><td>31797341</td><td>G</td><td char="." align="char">0.2659</td><td char="." align="char">0.6077</td><td char="." align="char">0.00621</td></tr>
###xml 1727 1736 1727 1736 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs9310978</td>
###xml 1736 1744 1736 1744 <td xmlns:xlink="http://www.w3.org/1999/xlink">31801771</td>
###xml 1744 1745 1744 1745 <td xmlns:xlink="http://www.w3.org/1999/xlink">T</td>
###xml 1745 1751 1745 1751 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.2656</td>
###xml 1751 1757 1751 1757 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.6085</td>
###xml 1757 1765 1757 1765 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.006334</td>
###xml 1727 1765 1727 1765 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs9310978</td><td>31801771</td><td>T</td><td char="." align="char">0.2656</td><td char="." align="char">0.6085</td><td char="." align="char">0.006334</td></tr>
###xml 1765 1774 1765 1774 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs3792551</td>
###xml 1774 1782 1774 1782 <td xmlns:xlink="http://www.w3.org/1999/xlink">31681904</td>
###xml 1782 1783 1782 1783 <td xmlns:xlink="http://www.w3.org/1999/xlink">T</td>
###xml 1783 1790 1783 1790 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.09962</td>
###xml 1790 1796 1790 1796 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.4152</td>
###xml 1796 1804 1796 1804 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.007563</td>
###xml 1765 1804 1765 1804 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs3792551</td><td>31681904</td><td>T</td><td char="." align="char">0.09962</td><td char="." align="char">0.4152</td><td char="." align="char">0.007563</td></tr>
###xml 1804 1814 1804 1814 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs12632849</td>
###xml 1814 1822 1814 1822 <td xmlns:xlink="http://www.w3.org/1999/xlink">31767922</td>
###xml 1822 1823 1822 1823 <td xmlns:xlink="http://www.w3.org/1999/xlink">T</td>
###xml 1823 1829 1823 1829 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.3582</td>
###xml 1829 1834 1829 1834 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.464</td>
###xml 1834 1841 1834 1841 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.00786</td>
###xml 1804 1841 1804 1841 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs12632849</td><td>31767922</td><td>T</td><td char="." align="char">0.3582</td><td char="." align="char">1.464</td><td char="." align="char">0.00786</td></tr>
###xml 1499 1841 1499 1841 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>rs11716163</td><td>31782580</td><td>T</td><td char="." align="char">0.2633</td><td char="." align="char">1.771</td><td char="." align="char">0.000179</td></tr><tr><td>rs7653447</td><td>31814139</td><td>A</td><td char="." align="char">0.3383</td><td char="." align="char">0.5882</td><td char="." align="char">0.001484</td></tr><tr><td>rs2168422</td><td>31779846</td><td>T</td><td char="." align="char">0.2921</td><td char="." align="char">0.5827</td><td char="." align="char">0.002511</td></tr><tr><td>rs9851048</td><td>31806124</td><td>T</td><td char="." align="char">0.3324</td><td char="." align="char">0.6091</td><td char="." align="char">0.003025</td></tr><tr><td>rs7643025</td><td>31814246</td><td>A</td><td char="." align="char">0.2527</td><td char="." align="char">0.5911</td><td char="." align="char">0.004931</td></tr><tr><td>rs12171283</td><td>31797341</td><td>G</td><td char="." align="char">0.2659</td><td char="." align="char">0.6077</td><td char="." align="char">0.00621</td></tr><tr><td>rs9310978</td><td>31801771</td><td>T</td><td char="." align="char">0.2656</td><td char="." align="char">0.6085</td><td char="." align="char">0.006334</td></tr><tr><td>rs3792551</td><td>31681904</td><td>T</td><td char="." align="char">0.09962</td><td char="." align="char">0.4152</td><td char="." align="char">0.007563</td></tr><tr><td>rs12632849</td><td>31767922</td><td>T</td><td char="." align="char">0.3582</td><td char="." align="char">1.464</td><td char="." align="char">0.00786</td></tr></tbody>
###xml 1433 1841 1433 1841 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>SNP</th><th>Position, bp</th><th>Effect allele</th><th>Effect all. frequency</th><th>Odds ratio</th><th>P-value</th></tr></thead><tbody><tr><td>rs11716163</td><td>31782580</td><td>T</td><td char="." align="char">0.2633</td><td char="." align="char">1.771</td><td char="." align="char">0.000179</td></tr><tr><td>rs7653447</td><td>31814139</td><td>A</td><td char="." align="char">0.3383</td><td char="." align="char">0.5882</td><td char="." align="char">0.001484</td></tr><tr><td>rs2168422</td><td>31779846</td><td>T</td><td char="." align="char">0.2921</td><td char="." align="char">0.5827</td><td char="." align="char">0.002511</td></tr><tr><td>rs9851048</td><td>31806124</td><td>T</td><td char="." align="char">0.3324</td><td char="." align="char">0.6091</td><td char="." align="char">0.003025</td></tr><tr><td>rs7643025</td><td>31814246</td><td>A</td><td char="." align="char">0.2527</td><td char="." align="char">0.5911</td><td char="." align="char">0.004931</td></tr><tr><td>rs12171283</td><td>31797341</td><td>G</td><td char="." align="char">0.2659</td><td char="." align="char">0.6077</td><td char="." align="char">0.00621</td></tr><tr><td>rs9310978</td><td>31801771</td><td>T</td><td char="." align="char">0.2656</td><td char="." align="char">0.6085</td><td char="." align="char">0.006334</td></tr><tr><td>rs3792551</td><td>31681904</td><td>T</td><td char="." align="char">0.09962</td><td char="." align="char">0.4152</td><td char="." align="char">0.007563</td></tr><tr><td>rs12632849</td><td>31767922</td><td>T</td><td char="." align="char">0.3582</td><td char="." align="char">1.464</td><td char="." align="char">0.00786</td></tr></tbody></table>
###xml 1337 1841 1337 1841 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="45">Genmets study material: <italic>OSBPL10</italic> SNPs associated with high TG (&gt;95th percentile), <italic>p</italic>&#8201;&lt;&#8201;0.01</p></caption><table frame="hsides" rules="groups"><thead><tr><th>SNP</th><th>Position, bp</th><th>Effect allele</th><th>Effect all. frequency</th><th>Odds ratio</th><th>P-value</th></tr></thead><tbody><tr><td>rs11716163</td><td>31782580</td><td>T</td><td char="." align="char">0.2633</td><td char="." align="char">1.771</td><td char="." align="char">0.000179</td></tr><tr><td>rs7653447</td><td>31814139</td><td>A</td><td char="." align="char">0.3383</td><td char="." align="char">0.5882</td><td char="." align="char">0.001484</td></tr><tr><td>rs2168422</td><td>31779846</td><td>T</td><td char="." align="char">0.2921</td><td char="." align="char">0.5827</td><td char="." align="char">0.002511</td></tr><tr><td>rs9851048</td><td>31806124</td><td>T</td><td char="." align="char">0.3324</td><td char="." align="char">0.6091</td><td char="." align="char">0.003025</td></tr><tr><td>rs7643025</td><td>31814246</td><td>A</td><td char="." align="char">0.2527</td><td char="." align="char">0.5911</td><td char="." align="char">0.004931</td></tr><tr><td>rs12171283</td><td>31797341</td><td>G</td><td char="." align="char">0.2659</td><td char="." align="char">0.6077</td><td char="." align="char">0.00621</td></tr><tr><td>rs9310978</td><td>31801771</td><td>T</td><td char="." align="char">0.2656</td><td char="." align="char">0.6085</td><td char="." align="char">0.006334</td></tr><tr><td>rs3792551</td><td>31681904</td><td>T</td><td char="." align="char">0.09962</td><td char="." align="char">0.4152</td><td char="." align="char">0.007563</td></tr><tr><td>rs12632849</td><td>31767922</td><td>T</td><td char="." align="char">0.3582</td><td char="." align="char">1.464</td><td char="." align="char">0.00786</td></tr></tbody></table></table-wrap>
Prompted by the suggestive linkage observation, we moved on to analyze the extreme ends of the HDL and TG distribution in a subcohort (Genmets) of the Health2000 population cohort, consisting of subjects with metabolic syndrome and matched healthy controls. Similar to the analysis done in the family sample, in this data set (N = 2,138) individuals with the TG above the 95th percentile were coded as cases and the rest as controls. A corresponding dichotomous division was made using HDL cholesterol <5th percentile as the cut-off. The analysis revealed association of multiple SNPs (21 SNPs with p < 0.05, nine SNPs with p < 0.01) in OSBPL10 or its flanking regions with high TG levels (Fig. 2a, Table 3). Also, a tendency of association with low HDL was observed, but this failed to reach statistical significance after multiple testing correction (Fig. 2b). The SNPs showing strongest association with high TG in the Genmets data set were, with the exception of one, located in OSBPL10 intron 5 and contained within a single LD block (Fig. 1). Fig. 2Association of OSBPL10 SNPs with high TG (>95th percentile) of low HDL (<5th percentile) in the Genmets study material. Expected and observed p values are depicted. The axes represent -log10 of the p values, the straight line indicating the expected p values assuming no associationTable 3Genmets study material: OSBPL10 SNPs associated with high TG (>95th percentile), p < 0.01SNPPosition, bpEffect alleleEffect all. frequencyOdds ratioP-valuers1171616331782580T0.26331.7710.000179rs765344731814139A0.33830.58820.001484rs216842231779846T0.29210.58270.002511rs985104831806124T0.33240.60910.003025rs764302531814246A0.25270.59110.004931rs1217128331797341G0.26590.60770.00621rs931097831801771T0.26560.60850.006334rs379255131681904T0.099620.41520.007563rs1263284931767922T0.35821.4640.00786
###end p 43
###begin p 44
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axes</italic>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 212 225 212 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">straight line</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Association of OSBPL10 SNPs with high TG (>95th percentile) of low HDL (<5th percentile) in the Genmets study material. Expected and observed p values are depicted. The axes represent -log10 of the p values, the straight line indicating the expected p values assuming no association
###end p 44
###begin p 45
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Genmets study material: OSBPL10 SNPs associated with high TG (>95th percentile), p < 0.01
###end p 45
###begin title 46
ORP10 modulates hepatocellular lipogenesis
###end title 46
###begin p 47
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3a</xref>
###xml 438 439 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 606 607 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 651 652 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3b</xref>
###xml 795 796 795 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 872 873 872 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3b</xref>
###xml 928 934 928 934 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1019 1020 1019 1020 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1123 1127 1123 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siNT</italic>
###xml 1155 1164 1155 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siORP10.1</italic>
###xml 1166 1175 1166 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siORP10.2</italic>
###xml 1404 1405 1401 1402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1424 1425 1421 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1458 1460 1455 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FC</italic>
###xml 1483 1485 1480 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CE</italic>
###xml 1507 1509 1504 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TG</italic>
###xml 1567 1568 1564 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1575 1576 1572 1573 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1619 1621 1616 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1759 1760 1756 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1767 1768 1764 1765 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1787 1788 1784 1785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1881 1882 1878 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 2064 2065 2059 2060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 2073 2074 2068 2069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2085 2086 2080 2081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 934 2093 934 2088 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">Silencing of ORP10 enhances cholesterol and triglyceride biosynthesis in Huh7 cells. <bold>a</bold> Western blot analysis of ORP10 protein level in cells transfected for 48&#160;h with nontargeting control (<italic>siNT</italic>) or ORP10-specific siRNAs (<italic>siORP10.1</italic>, <italic>siORP10.2</italic>) using INTERFERin. Anti-&#946;-actin was used as a control for equal protein loading. The apparent molecular mass of the protein detected by the antibody (85&#160;kDa) matches the ORP10 mass deduced from the cDNA sequence (83.97&#160;kDa). <bold>b</bold> Incorporation of [<sup>3</sup>H]acetate into free cholesterol (<italic>FC</italic>), cholesteryl esters (<italic>CE</italic>), and triglycerides (<italic>TG</italic>) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). <bold>c</bold> HMG-CoA reductase activity (expressed as [<sup>14</sup>C]HMG-CoA incorporation into mevalonic acid, DMP per milligrams membrane protein) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). <bold>d</bold> Incorporation of [<sup>3</sup>H]oleic acid into triglycerides (TG) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). The results represent mean &#177; s.e.m. Statistical significance of the differences between values obtained for siNT and the ORP10-specific siRNAs was evaluated using Student&#8217;s <italic>t</italic> test; *<italic>p</italic>&#8201;&lt;&#8201;0.05, **<italic>p</italic>&#8201;&lt;&#8201;0.01</p>
###xml 934 2093 934 2088 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48">Silencing of ORP10 enhances cholesterol and triglyceride biosynthesis in Huh7 cells. <bold>a</bold> Western blot analysis of ORP10 protein level in cells transfected for 48&#160;h with nontargeting control (<italic>siNT</italic>) or ORP10-specific siRNAs (<italic>siORP10.1</italic>, <italic>siORP10.2</italic>) using INTERFERin. Anti-&#946;-actin was used as a control for equal protein loading. The apparent molecular mass of the protein detected by the antibody (85&#160;kDa) matches the ORP10 mass deduced from the cDNA sequence (83.97&#160;kDa). <bold>b</bold> Incorporation of [<sup>3</sup>H]acetate into free cholesterol (<italic>FC</italic>), cholesteryl esters (<italic>CE</italic>), and triglycerides (<italic>TG</italic>) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). <bold>c</bold> HMG-CoA reductase activity (expressed as [<sup>14</sup>C]HMG-CoA incorporation into mevalonic acid, DMP per milligrams membrane protein) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). <bold>d</bold> Incorporation of [<sup>3</sup>H]oleic acid into triglycerides (TG) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). The results represent mean &#177; s.e.m. Statistical significance of the differences between values obtained for siNT and the ORP10-specific siRNAs was evaluated using Student&#8217;s <italic>t</italic> test; *<italic>p</italic>&#8201;&lt;&#8201;0.05, **<italic>p</italic>&#8201;&lt;&#8201;0.01</p></caption>
###xml 2093 2093 2088 2088 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_490_Fig3_HTML" id="MO3"/>
###xml 928 2093 928 2088 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="48">Silencing of ORP10 enhances cholesterol and triglyceride biosynthesis in Huh7 cells. <bold>a</bold> Western blot analysis of ORP10 protein level in cells transfected for 48&#160;h with nontargeting control (<italic>siNT</italic>) or ORP10-specific siRNAs (<italic>siORP10.1</italic>, <italic>siORP10.2</italic>) using INTERFERin. Anti-&#946;-actin was used as a control for equal protein loading. The apparent molecular mass of the protein detected by the antibody (85&#160;kDa) matches the ORP10 mass deduced from the cDNA sequence (83.97&#160;kDa). <bold>b</bold> Incorporation of [<sup>3</sup>H]acetate into free cholesterol (<italic>FC</italic>), cholesteryl esters (<italic>CE</italic>), and triglycerides (<italic>TG</italic>) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). <bold>c</bold> HMG-CoA reductase activity (expressed as [<sup>14</sup>C]HMG-CoA incorporation into mevalonic acid, DMP per milligrams membrane protein) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). <bold>d</bold> Incorporation of [<sup>3</sup>H]oleic acid into triglycerides (TG) in cells treated with control or ORP10-specific siRNAs (<italic>N</italic>&#8201;=&#8201;4). The results represent mean &#177; s.e.m. Statistical significance of the differences between values obtained for siNT and the ORP10-specific siRNAs was evaluated using Student&#8217;s <italic>t</italic> test; *<italic>p</italic>&#8201;&lt;&#8201;0.05, **<italic>p</italic>&#8201;&lt;&#8201;0.01</p></caption><graphic position="anchor" xlink:href="109_2009_490_Fig3_HTML" id="MO3"/></fig>
###xml 62 67 <span type="species:ncbi:9606">human</span>
We employed siRNA-mediated silencing of ORP10 expression in a human hepatoma cell line Huh7 to investigate the role of ORP10 in hepatocellular lipid biosyntheses. Transfection of the two independent siRNAs used, siORP10.1 and siORP10.2, resulted in approximately 90% reduction of the endogenous Huh7 cell ORP10 protein (Fig. 3a). To assess the role of ORP10 in hepatocellular cholesterol biosynthesis, we determined the incorporation of [3H]acetic acid into cholesterol in cells transfected with scrambled control or ORP10-specific siRNAs. Silencing of ORP10 resulted in a significant, 40-50% increase of [3H]free cholesterol and a mild elevation of [3H]cholesterol esters, suggesting enhancement of cholesterol biosynthetic activity (Fig. 3b). We also quantified from the same experiments the [3H]radioactivity incorporated into TG, revealing a significant elevation of [3H]TG in cells treated with the ORP10 siRNAs (Fig. 3b). Fig. 3Silencing of ORP10 enhances cholesterol and triglyceride biosynthesis in Huh7 cells. a Western blot analysis of ORP10 protein level in cells transfected for 48 h with nontargeting control (siNT) or ORP10-specific siRNAs (siORP10.1, siORP10.2) using INTERFERin. Anti-beta-actin was used as a control for equal protein loading. The apparent molecular mass of the protein detected by the antibody (85 kDa) matches the ORP10 mass deduced from the cDNA sequence (83.97 kDa). b Incorporation of [3H]acetate into free cholesterol (FC), cholesteryl esters (CE), and triglycerides (TG) in cells treated with control or ORP10-specific siRNAs (N = 4). c HMG-CoA reductase activity (expressed as [14C]HMG-CoA incorporation into mevalonic acid, DMP per milligrams membrane protein) in cells treated with control or ORP10-specific siRNAs (N = 4). d Incorporation of [3H]oleic acid into triglycerides (TG) in cells treated with control or ORP10-specific siRNAs (N = 4). The results represent mean +/- s.e.m. Statistical significance of the differences between values obtained for siNT and the ORP10-specific siRNAs was evaluated using Student's t test; *p < 0.05, **p < 0.01
###end p 47
###begin p 48
###xml 85 86 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siNT</italic>
###xml 221 230 221 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siORP10.1</italic>
###xml 232 241 232 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siORP10.2</italic>
###xml 470 471 467 468 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 490 491 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 524 526 521 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FC</italic>
###xml 549 551 546 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CE</italic>
###xml 573 575 570 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TG</italic>
###xml 633 634 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 641 642 638 639 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 685 687 682 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 825 826 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 833 834 830 831 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 853 854 850 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 947 948 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1130 1131 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1139 1140 1134 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1151 1152 1146 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Silencing of ORP10 enhances cholesterol and triglyceride biosynthesis in Huh7 cells. a Western blot analysis of ORP10 protein level in cells transfected for 48 h with nontargeting control (siNT) or ORP10-specific siRNAs (siORP10.1, siORP10.2) using INTERFERin. Anti-beta-actin was used as a control for equal protein loading. The apparent molecular mass of the protein detected by the antibody (85 kDa) matches the ORP10 mass deduced from the cDNA sequence (83.97 kDa). b Incorporation of [3H]acetate into free cholesterol (FC), cholesteryl esters (CE), and triglycerides (TG) in cells treated with control or ORP10-specific siRNAs (N = 4). c HMG-CoA reductase activity (expressed as [14C]HMG-CoA incorporation into mevalonic acid, DMP per milligrams membrane protein) in cells treated with control or ORP10-specific siRNAs (N = 4). d Incorporation of [3H]oleic acid into triglycerides (TG) in cells treated with control or ORP10-specific siRNAs (N = 4). The results represent mean +/- s.e.m. Statistical significance of the differences between values obtained for siNT and the ORP10-specific siRNAs was evaluated using Student's t test; *p < 0.05, **p < 0.01
###end p 48
###begin p 49
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 382 384 382 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3c</xref>
###xml 622 629 622 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 800 801 800 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 996 997 996 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3d</xref>
To investigate whether the elevation of [3H]cholesterol biosynthesis in Huh7 cells subjected to ORP10 silencing reflects a change in the activity of the rate-limiting enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, we determined in vitro the activity of this enzyme in membranes isolated from cells treated with ORP10-specific or control siRNAs. Incorporation of [14C]HMG-CoA into mevalonate was significantly (siORP10.1, 29%; siORP10.2, 21%) enhanced in cells subjected to ORP10 silencing as compared to those treated with the nontargeting control siRNA (Fig. 3c). Furthermore, to test if the effect of OSBPL10 silencing on TG biosynthesis occurs at the level of fatty acid biosynthesis or at the level of their activation or incorporation into TG, we assessed TG synthesis using [3H]oleic acid as the radioactive precursor. The results revealed enhancement in its incorporation into TG in cells subjected to ORP10 silencing, similar in its extent to the effect observed upon [3H]acetic acid labeling (Fig. 3d).
###end p 49
###begin p 50
###xml 470 475 470 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4a, b</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4c</xref>
###xml 762 763 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM3">2</xref>
###xml 766 772 766 772 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 875 876 875 876 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 891 892 891 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1129 1130 1127 1128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1130 1131 1128 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1137 1138 1135 1136 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1138 1139 1136 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1146 1147 1144 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1158 1159 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1168 1169 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1177 1178 1175 1176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 772 1369 772 1367 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="51">Silencing of ORP10 increases the accumulation of apoB100 in the growth medium. Accumulation of apoA-I (<bold>a</bold>) and apoB100 (<bold>b</bold>) into the growth medium of Huh7 cells treated with nontargeting (siNT) or ORP10-specific (siORP10.1, siORP10.2) siRNAs during a 24-h time course was quantified with specific sandwich ELISA assays. The data represents a mean &#177; s.e.m. (<bold>a</bold><italic>N</italic>&#8201;=&#8201;3, <bold>b</bold><italic>N</italic>&#8201;=&#8201;5; *<italic>p</italic>&#8201;&lt;&#8201;0.05, **<italic>p</italic>&#8201;&lt;&#8201;0.01, <italic>t</italic> test). <bold>c</bold> Analysis of apoB100 accumulation into growth medium at the indicated time points by Western blotting. An experiment representative of three independent analyses with similar results is shown</p>
###xml 772 1369 772 1367 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="51">Silencing of ORP10 increases the accumulation of apoB100 in the growth medium. Accumulation of apoA-I (<bold>a</bold>) and apoB100 (<bold>b</bold>) into the growth medium of Huh7 cells treated with nontargeting (siNT) or ORP10-specific (siORP10.1, siORP10.2) siRNAs during a 24-h time course was quantified with specific sandwich ELISA assays. The data represents a mean &#177; s.e.m. (<bold>a</bold><italic>N</italic>&#8201;=&#8201;3, <bold>b</bold><italic>N</italic>&#8201;=&#8201;5; *<italic>p</italic>&#8201;&lt;&#8201;0.05, **<italic>p</italic>&#8201;&lt;&#8201;0.01, <italic>t</italic> test). <bold>c</bold> Analysis of apoB100 accumulation into growth medium at the indicated time points by Western blotting. An experiment representative of three independent analyses with similar results is shown</p></caption>
###xml 1369 1369 1367 1367 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_490_Fig4_HTML" id="MO4"/>
###xml 766 1369 766 1367 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="51">Silencing of ORP10 increases the accumulation of apoB100 in the growth medium. Accumulation of apoA-I (<bold>a</bold>) and apoB100 (<bold>b</bold>) into the growth medium of Huh7 cells treated with nontargeting (siNT) or ORP10-specific (siORP10.1, siORP10.2) siRNAs during a 24-h time course was quantified with specific sandwich ELISA assays. The data represents a mean &#177; s.e.m. (<bold>a</bold><italic>N</italic>&#8201;=&#8201;3, <bold>b</bold><italic>N</italic>&#8201;=&#8201;5; *<italic>p</italic>&#8201;&lt;&#8201;0.05, **<italic>p</italic>&#8201;&lt;&#8201;0.01, <italic>t</italic> test). <bold>c</bold> Analysis of apoB100 accumulation into growth medium at the indicated time points by Western blotting. An experiment representative of three independent analyses with similar results is shown</p></caption><graphic position="anchor" xlink:href="109_2009_490_Fig4_HTML" id="MO4"/></fig>
To investigate whether ORP10 might impact lipoprotein secretion by hepatic cells, we transferred Huh7 cells subjected to ORP10 silencing into serum-free medium and quantified, using specific ELISA assays, the secretion of apoA-I and apoB100. During a time course of up to 24 h, reduction of the cellular ORP10 induced a significant increase in the amount of apoB100 that accumulated in the growth medium, while no effect was detected on the accumulation of apoA-I (Fig. 4a, b). At 12 h, the increase in apoB100 was 22% (siORP10.1) or 40% (siORP10.2) as compared to siNT-transfected cells; At 24 h, the corresponding numbers were 59% and 85%. Western analysis of the growth media was consistent with this finding (Fig. 4c; Electronic Supplementary Materials Fig. 2). Fig. 4Silencing of ORP10 increases the accumulation of apoB100 in the growth medium. Accumulation of apoA-I (a) and apoB100 (b) into the growth medium of Huh7 cells treated with nontargeting (siNT) or ORP10-specific (siORP10.1, siORP10.2) siRNAs during a 24-h time course was quantified with specific sandwich ELISA assays. The data represents a mean +/- s.e.m. (aN = 3, bN = 5; *p < 0.05, **p < 0.01, t test). c Analysis of apoB100 accumulation into growth medium at the indicated time points by Western blotting. An experiment representative of three independent analyses with similar results is shown
###end p 50
###begin p 51
###xml 103 104 103 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 357 358 355 356 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 358 359 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 365 366 363 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 366 367 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 374 375 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 386 387 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 396 397 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 405 406 403 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
Silencing of ORP10 increases the accumulation of apoB100 in the growth medium. Accumulation of apoA-I (a) and apoB100 (b) into the growth medium of Huh7 cells treated with nontargeting (siNT) or ORP10-specific (siORP10.1, siORP10.2) siRNAs during a 24-h time course was quantified with specific sandwich ELISA assays. The data represents a mean +/- s.e.m. (aN = 3, bN = 5; *p < 0.05, **p < 0.01, t test). c Analysis of apoB100 accumulation into growth medium at the indicated time points by Western blotting. An experiment representative of three independent analyses with similar results is shown
###end p 51
###begin p 52
###xml 173 174 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">,</italic>
###xml 427 434 420 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 441 442 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 445 451 438 444 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 648 658 641 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 671 680 664 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bars</italic>
###xml 764 769 757 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SREBP</italic>
###xml 813 816 806 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LXR</italic>
###xml 835 841 828 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGCoR</italic>
###xml 891 895 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLR</italic>
###xml 930 933 923 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABC</italic>
###xml 968 973 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insig</italic>
###xml 996 999 989 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FAS</italic>
###xml 1021 1024 1014 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCD</italic>
###xml 1229 1230 1220 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 451 1237 444 1228 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="53">OSBPL10 silencing has no significant effect on the mRNAs for key factors involved in lipid metabolism. Huh7 cells were transfected for 48&#160;h with control (siNT) or ORP10-specific siRNAs (siORP10.1, <italic>black bars</italic>; siORP10.2, <italic>gray bars</italic>), followed by total RNA isolation and quantitative RT-PCR analysis of mRNA levels. <italic>SREBP</italic> sterol regulatory element binding protein, <italic>LXR</italic> liver X receptor, <italic>HMGCoR</italic> 3-hydroxy-3-methylglutaryl coenzyme A reductase, <italic>LDLR</italic> low-density lipoprotein receptor, <italic>ABC</italic> ATP-binding cassette transporter, <italic>Insig</italic> insulin-induced gene, <italic>FAS</italic> fatty acyl synthase, <italic>SCD</italic> stearoyl coenzyme A desaturase-1. The data depict mRNA levels in ORP10 siRNA-treated cells relative to those in cells transfected with the scrambled control siRNA (siNT) and represents a mean &#177; s.e.m. (<italic>N</italic>&#8201;=&#8201;4&#8211;5)</p>
###xml 451 1237 444 1228 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="53">OSBPL10 silencing has no significant effect on the mRNAs for key factors involved in lipid metabolism. Huh7 cells were transfected for 48&#160;h with control (siNT) or ORP10-specific siRNAs (siORP10.1, <italic>black bars</italic>; siORP10.2, <italic>gray bars</italic>), followed by total RNA isolation and quantitative RT-PCR analysis of mRNA levels. <italic>SREBP</italic> sterol regulatory element binding protein, <italic>LXR</italic> liver X receptor, <italic>HMGCoR</italic> 3-hydroxy-3-methylglutaryl coenzyme A reductase, <italic>LDLR</italic> low-density lipoprotein receptor, <italic>ABC</italic> ATP-binding cassette transporter, <italic>Insig</italic> insulin-induced gene, <italic>FAS</italic> fatty acyl synthase, <italic>SCD</italic> stearoyl coenzyme A desaturase-1. The data depict mRNA levels in ORP10 siRNA-treated cells relative to those in cells transfected with the scrambled control siRNA (siNT) and represents a mean &#177; s.e.m. (<italic>N</italic>&#8201;=&#8201;4&#8211;5)</p></caption>
###xml 1237 1237 1228 1228 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_490_Fig5_HTML" id="MO5"/>
###xml 445 1237 438 1228 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="53">OSBPL10 silencing has no significant effect on the mRNAs for key factors involved in lipid metabolism. Huh7 cells were transfected for 48&#160;h with control (siNT) or ORP10-specific siRNAs (siORP10.1, <italic>black bars</italic>; siORP10.2, <italic>gray bars</italic>), followed by total RNA isolation and quantitative RT-PCR analysis of mRNA levels. <italic>SREBP</italic> sterol regulatory element binding protein, <italic>LXR</italic> liver X receptor, <italic>HMGCoR</italic> 3-hydroxy-3-methylglutaryl coenzyme A reductase, <italic>LDLR</italic> low-density lipoprotein receptor, <italic>ABC</italic> ATP-binding cassette transporter, <italic>Insig</italic> insulin-induced gene, <italic>FAS</italic> fatty acyl synthase, <italic>SCD</italic> stearoyl coenzyme A desaturase-1. The data depict mRNA levels in ORP10 siRNA-treated cells relative to those in cells transfected with the scrambled control siRNA (siNT) and represents a mean &#177; s.e.m. (<italic>N</italic>&#8201;=&#8201;4&#8211;5)</p></caption><graphic position="anchor" xlink:href="109_2009_490_Fig5_HTML" id="MO5"/></fig>
To obtain clues of the mechanism by which ORP10 impacts cellular lipid metabolism, we analyzed by quantitative real-time RT-PCR the mRNAs for LXRalpha, LXRbeta, ABCA1, ABCG1, ABCG5, SREBP-1a, SREBP-1c, SREBP-2, HMG-CoA reductase, LDL-receptor, fatty acyl synthetase, stearoyl-CoA desaturase 1, Insig-1, and Insig-2. No significant change consistent with both ORP10-specific siRNAs was observed in these mRNAs upon silencing of OSBPL10 (Fig. 5). Fig. 5OSBPL10 silencing has no significant effect on the mRNAs for key factors involved in lipid metabolism. Huh7 cells were transfected for 48 h with control (siNT) or ORP10-specific siRNAs (siORP10.1, black bars; siORP10.2, gray bars), followed by total RNA isolation and quantitative RT-PCR analysis of mRNA levels. SREBP sterol regulatory element binding protein, LXR liver X receptor, HMGCoR 3-hydroxy-3-methylglutaryl coenzyme A reductase, LDLR low-density lipoprotein receptor, ABC ATP-binding cassette transporter, Insig insulin-induced gene, FAS fatty acyl synthase, SCD stearoyl coenzyme A desaturase-1. The data depict mRNA levels in ORP10 siRNA-treated cells relative to those in cells transfected with the scrambled control siRNA (siNT) and represents a mean +/- s.e.m. (N = 4-5)
###end p 52
###begin p 53
###xml 197 207 197 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 220 229 220 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bars</italic>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SREBP</italic>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LXR</italic>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGCoR</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLR</italic>
###xml 479 482 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABC</italic>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insig</italic>
###xml 545 548 545 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FAS</italic>
###xml 570 573 570 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCD</italic>
###xml 778 779 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
OSBPL10 silencing has no significant effect on the mRNAs for key factors involved in lipid metabolism. Huh7 cells were transfected for 48 h with control (siNT) or ORP10-specific siRNAs (siORP10.1, black bars; siORP10.2, gray bars), followed by total RNA isolation and quantitative RT-PCR analysis of mRNA levels. SREBP sterol regulatory element binding protein, LXR liver X receptor, HMGCoR 3-hydroxy-3-methylglutaryl coenzyme A reductase, LDLR low-density lipoprotein receptor, ABC ATP-binding cassette transporter, Insig insulin-induced gene, FAS fatty acyl synthase, SCD stearoyl coenzyme A desaturase-1. The data depict mRNA levels in ORP10 siRNA-treated cells relative to those in cells transfected with the scrambled control siRNA (siNT) and represents a mean +/- s.e.m. (N = 4-5)
###end p 53
###begin title 54
ORP10 localizes on microtubules
###end title 54
###begin p 55
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6a</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6b</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6c</xref>
###xml 875 879 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6d&#8211;f</xref>
###xml 1293 1295 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6g</xref>
###xml 1690 1695 1680 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6h, i</xref>
###xml 1745 1747 1735 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6j</xref>
###xml 1897 1899 1887 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6k</xref>
###xml 2564 2570 2551 2557 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 2715 2716 2702 2703 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2741 2742 2728 2729 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2770 2771 2757 2758 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2799 2800 2786 2787 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 2801 2802 2788 2789 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 2830 2835 2817 2822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 2871 2881 2858 2868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowheads</italic>
###xml 3113 3114 3097 3098 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 3211 3212 3194 3195 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 3214 3215 3197 3198 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 3431 3437 3406 3412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 3440 3441 3415 3416 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 3500 3505 3475 3480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 3530 3533 3505 3508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 3536 3537 3511 3512 <bold xmlns:xlink="http://www.w3.org/1999/xlink">k</bold>
###xml 3678 3682 3644 3648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bars</italic>
###xml 3691 3692 3656 3657 <bold xmlns:xlink="http://www.w3.org/1999/xlink">l</bold>
###xml 4009 4010 3973 3974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 4034 4035 3996 3997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 4035 4036 3997 3998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2570 4147 2557 4105 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="56">ORP10 localizes on microtubules. Huh7, Caco-2, and PANC-1 cells transfected with EGFP-ORP10 were visualized by confocal fluorescence microscopy. <bold>a</bold> Transfected Huh7 cells. <bold>b</bold> A transfected Caco-2 cell. <bold>c</bold> A transfected PANC-1 cell. <bold>d</bold>&#8211;<bold>f</bold> A transfected PANC-1 cell (<italic>arrow</italic>) surrounded by untransfected ones (<italic>arrowheads</italic>), costained with an antibody against &#946;-tubulin. Note the aberrant bundled morphology of the EGFP-ORP10-positive microtubules in the transfected cell as compared to the normal microtubule cytoskeleton in the untransfected cells. <bold>g</bold> A transfected PANC-1 cell treated for 1&#160;h with demecolcine (10&#8201;&#956;g/ml) to disrupt microtubules. <bold>h</bold>, <bold>i</bold> A transfected PANC-1 cell after 2&#160;h treatment with vinblastine (10&#8201;&#956;g/ml), an agent that binds to &#945;- and &#946;-tubulin, prevents their polymerization and allows formation of tubulin paracrystals (indicated with <italic>arrows</italic>). <bold>j</bold> Channel merge image of a Huh7 cell expressing EGFP-ORP10 (<italic>green</italic>), stained for vimentin (<italic>red</italic>). <bold>k</bold> Huh7 cells transfected with ORP10/pcDNA4HisMaxC encoding ORP10 devoid of the EGFP fusion partner (staining with Xpress&#8482; antibody). <italic>Bars</italic> 10&#8201;&#956;m. <bold>l</bold>. Huh7 cells transfected with EGFP-ORP10 were subjected to fluorescence recovery after photobleaching analysis using a live cell confocal microscopy setup. The recovery curve representing microtubule associated fluorescence in a bleached 6&#8201;&#215;&#8201;6&#8201;&#956;m area as a function of time is displayed. The data represents a mean (<italic>N</italic>&#8201;=&#8201;8 cells) &#177; s.e.m.; <italic>R</italic><sup>2</sup> of the fit&#8201;=&#8201;0.9993. Recovery half times for the two kinetic components are 4.5&#8201;&#177;&#8201;0.94&#160;s and 64.3&#8201;&#177;&#8201;11.6&#160;s</p>
###xml 2570 4147 2557 4105 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="56">ORP10 localizes on microtubules. Huh7, Caco-2, and PANC-1 cells transfected with EGFP-ORP10 were visualized by confocal fluorescence microscopy. <bold>a</bold> Transfected Huh7 cells. <bold>b</bold> A transfected Caco-2 cell. <bold>c</bold> A transfected PANC-1 cell. <bold>d</bold>&#8211;<bold>f</bold> A transfected PANC-1 cell (<italic>arrow</italic>) surrounded by untransfected ones (<italic>arrowheads</italic>), costained with an antibody against &#946;-tubulin. Note the aberrant bundled morphology of the EGFP-ORP10-positive microtubules in the transfected cell as compared to the normal microtubule cytoskeleton in the untransfected cells. <bold>g</bold> A transfected PANC-1 cell treated for 1&#160;h with demecolcine (10&#8201;&#956;g/ml) to disrupt microtubules. <bold>h</bold>, <bold>i</bold> A transfected PANC-1 cell after 2&#160;h treatment with vinblastine (10&#8201;&#956;g/ml), an agent that binds to &#945;- and &#946;-tubulin, prevents their polymerization and allows formation of tubulin paracrystals (indicated with <italic>arrows</italic>). <bold>j</bold> Channel merge image of a Huh7 cell expressing EGFP-ORP10 (<italic>green</italic>), stained for vimentin (<italic>red</italic>). <bold>k</bold> Huh7 cells transfected with ORP10/pcDNA4HisMaxC encoding ORP10 devoid of the EGFP fusion partner (staining with Xpress&#8482; antibody). <italic>Bars</italic> 10&#8201;&#956;m. <bold>l</bold>. Huh7 cells transfected with EGFP-ORP10 were subjected to fluorescence recovery after photobleaching analysis using a live cell confocal microscopy setup. The recovery curve representing microtubule associated fluorescence in a bleached 6&#8201;&#215;&#8201;6&#8201;&#956;m area as a function of time is displayed. The data represents a mean (<italic>N</italic>&#8201;=&#8201;8 cells) &#177; s.e.m.; <italic>R</italic><sup>2</sup> of the fit&#8201;=&#8201;0.9993. Recovery half times for the two kinetic components are 4.5&#8201;&#177;&#8201;0.94&#160;s and 64.3&#8201;&#177;&#8201;11.6&#160;s</p></caption>
###xml 4147 4147 4105 4105 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_490_Fig6_HTML" id="MO6"/>
###xml 2564 4147 2551 4105 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="56">ORP10 localizes on microtubules. Huh7, Caco-2, and PANC-1 cells transfected with EGFP-ORP10 were visualized by confocal fluorescence microscopy. <bold>a</bold> Transfected Huh7 cells. <bold>b</bold> A transfected Caco-2 cell. <bold>c</bold> A transfected PANC-1 cell. <bold>d</bold>&#8211;<bold>f</bold> A transfected PANC-1 cell (<italic>arrow</italic>) surrounded by untransfected ones (<italic>arrowheads</italic>), costained with an antibody against &#946;-tubulin. Note the aberrant bundled morphology of the EGFP-ORP10-positive microtubules in the transfected cell as compared to the normal microtubule cytoskeleton in the untransfected cells. <bold>g</bold> A transfected PANC-1 cell treated for 1&#160;h with demecolcine (10&#8201;&#956;g/ml) to disrupt microtubules. <bold>h</bold>, <bold>i</bold> A transfected PANC-1 cell after 2&#160;h treatment with vinblastine (10&#8201;&#956;g/ml), an agent that binds to &#945;- and &#946;-tubulin, prevents their polymerization and allows formation of tubulin paracrystals (indicated with <italic>arrows</italic>). <bold>j</bold> Channel merge image of a Huh7 cell expressing EGFP-ORP10 (<italic>green</italic>), stained for vimentin (<italic>red</italic>). <bold>k</bold> Huh7 cells transfected with ORP10/pcDNA4HisMaxC encoding ORP10 devoid of the EGFP fusion partner (staining with Xpress&#8482; antibody). <italic>Bars</italic> 10&#8201;&#956;m. <bold>l</bold>. Huh7 cells transfected with EGFP-ORP10 were subjected to fluorescence recovery after photobleaching analysis using a live cell confocal microscopy setup. The recovery curve representing microtubule associated fluorescence in a bleached 6&#8201;&#215;&#8201;6&#8201;&#956;m area as a function of time is displayed. The data represents a mean (<italic>N</italic>&#8201;=&#8201;8 cells) &#177; s.e.m.; <italic>R</italic><sup>2</sup> of the fit&#8201;=&#8201;0.9993. Recovery half times for the two kinetic components are 4.5&#8201;&#177;&#8201;0.94&#160;s and 64.3&#8201;&#177;&#8201;11.6&#160;s</p></caption><graphic position="anchor" xlink:href="109_2009_490_Fig6_HTML" id="MO6"/></fig>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
###xml 2272 2277 <span type="species:ncbi:9606">human</span>
To obtain clues of ORP10 function, we determined its intracellular localization. We transfected the human cell lines Huh7 (hepatoma), Caco-2 (colon carcinoma), and PANC-1 (pancreatic carcinoma) with EGFP- or Xpress epitope-tagged cDNA constructs and visualized the expressed proteins by confocal microscopy. The expressed ORP10 distributed between a cytosolic-appearing pool and fibril-like structures (Huh7, Fig. 6a; Caco-2, Fig. 6b; PANC-1, Fig. 6c). Especially in cells expressing the protein at high levels, the fibrils often showed a cable-like, undulating morphology. The ORP10 fluorescence co-localized extensively with beta-tubulin, identifying the filaments as microtubules. Localization of ORP10 on cable-like microtubule elements and the morphologic change induced by excess ORP10 were especially prominent in the human pancreatic carcinoma cell line PANC-1 (Fig. 6d-f; note the normal microtubule morphology in untransfected cells). However, ORP10 silencing using siRNA did not significantly affect the overall morphology of the microtubule cytoskeleton (data not shown). The identity of the ORP10 fibrils was further confirmed by treatment of transfected cells with the microtubule depolymerizing agent demecolcine, resulting in a dispersed, cytosolic distribution of ORP10 (Fig. 6g). To investigate further the microtubule association of ORP10, PANC-1 cells expressing ORP10 were treated with vinblastine, which binds to alpha- and beta-tubulin, prevents their polymerization, and allows formation of paracrystals consisting of both tubulins. ORP10 was found to decorate tubulin crystals in the vinblastine-treated cells, suggesting an intimate association with tubulin (Fig. 6h, i). No colocalization of ORP10 with vimentin (Fig. 6j) or cytokeratin (data not shown) intermediate filaments was observed. Identical results were obtained with the EGFP- and Xpress-epitope-tagged (Fig. 6k) constructs. To investigate whether manipulation of the cellular lipid status affects the localization of ORP10, we incubated Huh7 cells expressing EGFP-ORP10 for 48 h in lipoprotein-deficient medium. For some specimens, 50 muM lovastatin was added for 24 h to potentiate the lipid/sterol depletion. For a comparison, cells were also incubated for 48 h with 100 mug/ml of human LDL to increase the cellular lipid/sterol content or treated for 4 h with 5 muM 25-hydroxycholesterol. Fluorescence microscopy analysis of EGFP-ORP10 revealed no significant effect of the lipid manipulations on the steady-state subcellular distribution of the protein (data not shown). Fig. 6ORP10 localizes on microtubules. Huh7, Caco-2, and PANC-1 cells transfected with EGFP-ORP10 were visualized by confocal fluorescence microscopy. a Transfected Huh7 cells. b A transfected Caco-2 cell. c A transfected PANC-1 cell. d-f A transfected PANC-1 cell (arrow) surrounded by untransfected ones (arrowheads), costained with an antibody against beta-tubulin. Note the aberrant bundled morphology of the EGFP-ORP10-positive microtubules in the transfected cell as compared to the normal microtubule cytoskeleton in the untransfected cells. g A transfected PANC-1 cell treated for 1 h with demecolcine (10 mug/ml) to disrupt microtubules. h, i A transfected PANC-1 cell after 2 h treatment with vinblastine (10 mug/ml), an agent that binds to alpha- and beta-tubulin, prevents their polymerization and allows formation of tubulin paracrystals (indicated with arrows). j Channel merge image of a Huh7 cell expressing EGFP-ORP10 (green), stained for vimentin (red). k Huh7 cells transfected with ORP10/pcDNA4HisMaxC encoding ORP10 devoid of the EGFP fusion partner (staining with Xpresstrade mark antibody). Bars 10 mum. l. Huh7 cells transfected with EGFP-ORP10 were subjected to fluorescence recovery after photobleaching analysis using a live cell confocal microscopy setup. The recovery curve representing microtubule associated fluorescence in a bleached 6 x 6 mum area as a function of time is displayed. The data represents a mean (N = 8 cells) +/- s.e.m.; R2 of the fit = 0.9993. Recovery half times for the two kinetic components are 4.5 +/- 0.94 s and 64.3 +/- 11.6 s
###end p 55
###begin p 56
###xml 145 146 145 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 171 172 171 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 200 201 200 201 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 229 230 229 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 231 232 231 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 301 311 301 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowheads</italic>
###xml 543 544 540 541 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 641 642 637 638 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 644 645 640 641 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 861 867 849 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 870 871 858 859 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 930 935 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 960 963 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 966 967 954 955 <bold xmlns:xlink="http://www.w3.org/1999/xlink">k</bold>
###xml 1108 1112 1087 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bars</italic>
###xml 1121 1122 1099 1100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">l</bold>
###xml 1439 1440 1416 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1464 1465 1439 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1465 1466 1440 1441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
ORP10 localizes on microtubules. Huh7, Caco-2, and PANC-1 cells transfected with EGFP-ORP10 were visualized by confocal fluorescence microscopy. a Transfected Huh7 cells. b A transfected Caco-2 cell. c A transfected PANC-1 cell. d-f A transfected PANC-1 cell (arrow) surrounded by untransfected ones (arrowheads), costained with an antibody against beta-tubulin. Note the aberrant bundled morphology of the EGFP-ORP10-positive microtubules in the transfected cell as compared to the normal microtubule cytoskeleton in the untransfected cells. g A transfected PANC-1 cell treated for 1 h with demecolcine (10 mug/ml) to disrupt microtubules. h, i A transfected PANC-1 cell after 2 h treatment with vinblastine (10 mug/ml), an agent that binds to alpha- and beta-tubulin, prevents their polymerization and allows formation of tubulin paracrystals (indicated with arrows). j Channel merge image of a Huh7 cell expressing EGFP-ORP10 (green), stained for vimentin (red). k Huh7 cells transfected with ORP10/pcDNA4HisMaxC encoding ORP10 devoid of the EGFP fusion partner (staining with Xpresstrade mark antibody). Bars 10 mum. l. Huh7 cells transfected with EGFP-ORP10 were subjected to fluorescence recovery after photobleaching analysis using a live cell confocal microscopy setup. The recovery curve representing microtubule associated fluorescence in a bleached 6 x 6 mum area as a function of time is displayed. The data represents a mean (N = 8 cells) +/- s.e.m.; R2 of the fit = 0.9993. Recovery half times for the two kinetic components are 4.5 +/- 0.94 s and 64.3 +/- 11.6 s
###end p 56
###begin p 57
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6l</xref>
###xml 398 450 398 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">Electronic Supplementary Materials: Time lapse video</xref>
###xml 550 551 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 551 554 551 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sub>
To investigate the dynamic parameters of EGFP-ORP10 microtubule association, transfected Huh7 cells were subjected to fluorescence recovery after photobleaching analysis using a confocal microscope set up for live cell analysis. After photobleaching the microtubule-associated EGFP-ORP10, fluorescence recovered to approximately 70% of the starting value during the 6-min analysis period (Fig. 6l; Electronic Supplementary Materials: Time lapse video). The recovery followed a kinetics which curve-fitting suggested to arise from two components. The t1/2 for the fast component was 4.5 +/- 0.94 s, and that for the slow one was 64.3 +/- 11.6 s.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL</italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL</italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL</italic>
###xml 880 887 880 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 1165 1172 1165 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 137 143 <span type="species:ncbi:9606">humans</span>
In the present study, we investigated a putative function of OSBP-related proteins in the regulation of serum lipids and lipoproteins in humans. Genotyping of OSBPL gene SNPs in a dyslipidemic family material was initially used to evaluate the contribution of OSBPL genes to extreme lipid levels predisposing to cardiovascular disease, high triglycerides, and low HDL. Although recent genome-wide association studies [21-23] have initially identified common variants affecting lipid concentrations at the population level, data are also emerging for the impact of multiple rare variants influencing the extreme lipid levels [24]. Here, we wanted to study such potential loci by testing the involvement of select OSBPL genes in carefully phenotyped Finnish families ascertained for dyslipidemias, low HDL, or FCHL. The FCHL study set revealed suggestive linkage of several SNPs in OSBPL10 to the high TG trait, and analysis of the combined material strengthened the evidence. Importantly, association analysis using an independent study sample consisting of subjects with metabolic syndrome and matched healthy controls provided substantial proof for association of OSBPL10 SNPs with the extreme end (>95th percentile) high-TG trait.
###end p 59
###begin p 60
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 248 255 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 578 585 578 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
The genetic analyses suggest that variation within the chromosome 3p23 region containing OSBPL10 may contribute to the high TG levels in Finnish dyslipidemic subjects. The present data do not allow us to firmly conclude that the underlying gene is OSBPL10, but they prompted us to investigate in more detail the function of the encoded protein, ORP10, in cultured cell models. The metabolic studies in cultured cells subjected to ORP10 silencing identify the protein as a novel regulator of hepatocellular lipid metabolism and apoB100 secretion, consistent with the notion that OSBPL10 may be the gene underlying the genetic findings. The likelihood of this is further increased by the lack of other genes plausibly connected with lipid metabolism within the chromosome region (10 Mb interval).
###end p 60
###begin p 61
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 691 692 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1135 1142 1135 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OSBPL10</italic>
###xml 1173 1174 1173 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
Hepatoma cells subjected to ORP10 silencing displayed a significant increase in the incorporation of [3H]acetate into cholesterol and of [3H]acetate and [3H]oleic acid into TG, suggesting that the intrinsic function of ORP10 involves suppression of hepatocellular lipid biosyntheses. Consistent with this observation, the cells showed increased HMG-CoA reductase activity, demonstrating an effect already at an early stage of the pathway, on conversion of HMG-CoA to mevalonic acid. An independent, systematic esiRNA silencing screen of all ORP family members carried out in HeLa cells supported a role of ORP10 in the regulation of cholesterol biosynthesis (data not shown). Labeling with [3H]oleic acid suggested that the impact of ORP10 on TG biosynthesis occurs at the levels of fatty acid activation or acyl transfer to glycerol. Importantly, we also found that ORP10 silencing enhances the accumulation of apoB100 in the hepatoma cell growth medium. One can envision that ORP10 could affect the synthesis of TG and cholesterol as well as the assembly of TG-rich lipoproteins in the intestine and the liver, both tissues in which OSBPL10 mRNA is expressed abundantly [4].
###end p 61
###begin p 62
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 367 368 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 368 371 368 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sub>
###xml 474 475 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 475 478 475 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sub>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 751 756 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
ORP10 was found to distribute between a cytosolic localization and microtubules, a major apparatus determining the spatial distribution of organelles and forming tracks for intracellular transport events [25]. FRAP analysis of live Huh7 cells with EGFP-ORP10 on microtubules revealed a recovery with two kinetic components. We find it likely that the fast component (t1/2 = 4.5 s) reflects the diffusion of EGFP-ORP10 in the cytosolic compartment, while the slow component (t1/2 = 64.3 s) could represent the actual microtubule association of the protein. The latter half-time is in the same range as the life-times determined for transport carriers moving along microtubules from the endoplasmic reticulum (ER) to the Golgi complex [26] and from the trans-Golgi network to the plasma membrane [27, 28]. The data are thus consistent with the notion that ORP10 could be involved in microtubule-dependent membrane trafficking or organelle motility.
###end p 62
###begin p 63
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
Microtubule-dependent membrane trafficking is intimately connected with the control of lipid metabolism. Importantly, the membrane compartments that play key roles in the cellular metabolism of cholesterol and triglycerides, the ER and cytoplasmic lipid droplets, are connected to microtubules, which determine the spatial organization of the ER [29] and control the distribution and motility of lipid droplets [30, 31]. Pertinent to serum lipoproteins, also the Golgi complex playing a central role in lipoprotein secretion is organized by microtubules [32]. One can therefore envision that a protein associated with microtubules, such as ORP10, is in the position to modulate cellular lipid metabolism and lipoprotein secretion.
###end p 63
###begin title 64
Electronic Supplementary Materials
###end title 64
###begin p 65
Below is the link to the electronic supplementary material. 
###end p 65
###begin p 66
(AVI 3486 kb)
###end p 66
###begin p 67
(PDF 27 kb)
###end p 67
###begin p 68
(PDF 735 kb)
###end p 68
###begin p 69
(PDF 44 kb)
###end p 69
###begin p 70
We are grateful to Pipsa Kaipainen, Sari Nuutinen, Marja-Leena Piironen, Seija Puomilahti, and Pirjo Ranta for expert technical assistance. Dr. Markku Lehto is thanked for kindly providing the full-length ORP10 cDNA, Pekka Ellonen for help with the genotyping work, and Dr. Matti Jauhiainen for valuable comments on the manuscript. This study was supported by The Academy of Finland (grants 113013, 118720, and 121457 to V.M.O.), the European Union FP7 (LipidomicNet, agreement no. 202272), the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research (M.-R.T., V.M.O.), the Magnus Ehrnrooth Foundation (V.M.O.), the Finnish Cultural Foundation (V.M.O.), and Helsinki University Central Hospital: A special governmental subsidy for health sciences research (M.-R.T., I.V.). Further support was provided by The Center of Excellence in Complex Disease Genetics (L.P., K.M., J.N.), The Research Program of Molecular Medicine, University of Helsinki, Biomedicum Foundation, and Biocentrum Helsinki Foundation (L.P., M.-R.T., K.M., J.N.).
###end p 70
###begin p 71
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Disclosure statement</bold>
Disclosure statement Concerning this work, the authors have no conflicts of interest to declare.
###end p 71
###begin p 72
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Emerging roles of the oxysterol-binding protein family in metabolism, transport, and signaling
###end article-title 74
###begin article-title 75
Characteristics of oxysterol binding proteins
###end article-title 75
###begin article-title 76
###xml 15 20 <span type="species:ncbi:9606">human</span>
A family of 12 human genes containing oxysterol-binding domains
###end article-title 76
###begin article-title 77
###xml 35 41 <span type="species:ncbi:9606">humans</span>
The OSBP-related protein family in humans
###end article-title 77
###begin article-title 78
Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein
###end article-title 78
###begin article-title 79
OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation
###end article-title 79
###begin article-title 80
Oxysterol binding protein induces upregulation of SREBP-1c and enhances hepatic lipogenesis
###end article-title 80
###begin article-title 81
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
Expression of human OSBP-related protein 1L in macrophages enhances atherosclerotic lesion development in LDL receptor-deficient mice
###end article-title 81
###begin article-title 82
OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages
###end article-title 82
###begin article-title 83
Oxysterol binding protein-related Protein 9 (ORP9) is a cholesterol transfer protein that regulates Golgi structure and function
###end article-title 83
###begin article-title 84
Oxysterol-binding-protein (OSBP)-related protein 4 binds 25-hydroxycholesterol and interacts with vimentin intermediate filaments
###end article-title 84
###begin article-title 85
###xml 34 42 <span type="species:ncbi:9606">patients</span>
Familial lipoprotein disorders in patients with premature coronary artery disease
###end article-title 85
###begin article-title 86
Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
###end article-title 86
###begin article-title 87
Family study of serum lipids and lipoproteins in coronary heart-disease
###end article-title 87
###begin article-title 88
Atheroprotective mechanisms of HDL
###end article-title 88
###begin article-title 89
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23
###end article-title 89
###begin article-title 90
Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 115 130 <span type="species:ncbi:10090">transgenic mice</span>
Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice
###end article-title 91
###begin article-title 92
Assays for interaction between Rab7 and oxysterol binding protein related protein 1L (ORP1L)
###end article-title 92
###begin article-title 93
###xml 129 135 <span type="species:ncbi:9606">humans</span>
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
###end article-title 93
###begin article-title 94
Common variants at 30 loci contribute to polygenic dyslipidemia
###end article-title 94
###begin article-title 95
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
###end article-title 95
###begin article-title 96
Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels
###end article-title 96
###begin article-title 97
Bidirectional transport along microtubules
###end article-title 97
###begin article-title 98
ER-to-Golgi transport visualized in living cells
###end article-title 98
###begin article-title 99
Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells
###end article-title 99
###begin article-title 100
Dual-color visualization of trans-Golgi network to plasma membrane traffic along microtubules in living cells
###end article-title 100
###begin article-title 101
Morphogenesis of the endoplasmic reticulum: beyond active membrane expansion
###end article-title 101
###begin article-title 102
Microtubule motors: LSD2 trips the toggle
###end article-title 102
###begin article-title 103
Regulation of lipid-droplet transport by the perilipin homolog LSD2
###end article-title 103
###begin article-title 104
The Golgi apparatus at the cell centre
###end article-title 104
###begin p 105
###xml 0 5 <span type="species:ncbi:33453">Julia</span>
Julia Perttila and Krista Merikanto contributed equally to this work.
###end p 105
###begin p 106
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 106
###begin p 107
The online version of this article (doi:10.1007/s00109-009-0490-z) contains supplementary material, which is available to authorized users.
###end p 107

